<?xml version="1.0" encoding="UTF-8"?>

<article xmlns:xlink="http://www.w3.org/1999/xlink" xml:lang="en" dtd-version="1.0" article-type="reference-list">
<front>
<article-meta>
<custom-meta-group>
<custom-meta><meta-name>TotalReferences</meta-name><meta-value>98</meta-value></custom-meta>
<custom-meta><meta-name>ReferencesParsed</meta-name><meta-value>87</meta-value></custom-meta>
<custom-meta><meta-name>ReferencesBillable</meta-name><meta-value>89</meta-value></custom-meta>
<custom-meta><meta-name>LinkServices</meta-name><meta-value>pubmed-crossref</meta-value></custom-meta>
<custom-meta><meta-name>ReferencesLinked</meta-name><meta-value>87</meta-value></custom-meta>
<custom-meta><meta-name>ReferencesLinkedDOI</meta-name><meta-value>81</meta-value></custom-meta>
<custom-meta><meta-name>ReferencesLinkedPMID</meta-name><meta-value>84</meta-value></custom-meta>
<custom-meta><meta-name>JournalReferences</meta-name><meta-value>86</meta-value></custom-meta>
<custom-meta><meta-name>BookReferences</meta-name><meta-value>0</meta-value></custom-meta>
<custom-meta><meta-name>BookChapterReferences</meta-name><meta-value>2</meta-value></custom-meta>
<custom-meta><meta-name>ConferenceReferences</meta-name><meta-value>2</meta-value></custom-meta>
<custom-meta><meta-name>ElectronicReferences</meta-name><meta-value>2</meta-value></custom-meta>
<custom-meta><meta-name>DissertationReferences</meta-name><meta-value>0</meta-value></custom-meta>
<custom-meta><meta-name>LegalReferences</meta-name><meta-value>0</meta-value></custom-meta>
<custom-meta><meta-name>StandardReferences</meta-name><meta-value>0</meta-value></custom-meta>
<custom-meta><meta-name>OtherReferences</meta-name><meta-value>0</meta-value></custom-meta>
<custom-meta><meta-name>UnknownReferences</meta-name><meta-value>6</meta-value></custom-meta>
<custom-meta><meta-name>ReferencesSemiParsed</meta-name><meta-value>0</meta-value></custom-meta>
<custom-meta><meta-name>ReferencesBookUnparsed</meta-name><meta-value>1</meta-value></custom-meta>
<custom-meta><meta-name>EditorialStyle</meta-name><meta-value>ICMJE-WHO</meta-value></custom-meta>
</custom-meta-group>
</article-meta>
</front>
<back>
<ref-list>
<ref id="b1"><mixed-citation publication-type="journal" specific-use="restruct"><person-group person-group-type="author"><string-name><surname>Levin</surname> <given-names>M</given-names></string-name>, <string-name><surname>Ward</surname> <given-names>TN</given-names></string-name></person-group>. <article-title>Horton’s disease: past and present</article-title>. <source>Curr Pain Headache Rep</source>. <year>2005</year> <month>Aug</month>;<volume>9</volume>(<issue>4</issue>):<fpage>259</fpage>–<lpage>63</lpage>. <pub-id pub-id-type="doi">10.1007/s11916-005-0033-4</pub-id><pub-id pub-id-type="pmid">16004841</pub-id><issn>1531-3433</issn><annotation><p content-type="warning">Based on PubMed data, Edifix has added authors to this reference. The original author was "<underline>Levin</underline>". Please check carefully as this change may affect the in-text citations. (Ref. "Levin, Ward, 2005")</p></annotation></mixed-citation></ref>
<ref id="b2"><mixed-citation publication-type="journal" specific-use="restruct"><person-group person-group-type="author"><string-name><surname>Watts</surname> <given-names>RA</given-names></string-name>, <string-name><surname>Suppiah</surname> <given-names>R</given-names></string-name>, <string-name><surname>Merkel</surname> <given-names>PA</given-names></string-name>, <string-name><surname>Luqmani</surname> <given-names>R</given-names></string-name></person-group>. <article-title>Systemic vasculitis—is it time to reclassify?</article-title> <source>Rheumatology (Oxford)</source>. <year>2011</year> <month>Apr</month>;<volume>50</volume>(<issue>4</issue>):<fpage>643</fpage>–<lpage>5</lpage>. <pub-id pub-id-type="doi">10.1093/rheumatology/keq229</pub-id><pub-id pub-id-type="pmid">20647295</pub-id><issn>1462-0324</issn><annotation><p content-type="warning">Based on PubMed data, Edifix has added authors to this reference. The original author was "<underline>Watts</underline>". Please check carefully as this change may affect the in-text citations. (Ref. "Watts, Suppiah, Merkel, Luqmani, 2011")</p></annotation></mixed-citation></ref>
<ref id="b3"><mixed-citation publication-type="journal" specific-use="restruct"><person-group person-group-type="author"><string-name><surname>Borchers</surname> <given-names>AT</given-names></string-name>, <string-name><surname>Gershwin</surname> <given-names>ME</given-names></string-name></person-group>. <article-title>Giant cell arteritis: a review of classification, pathophysiology, geoepidemiology and treatment</article-title>. <source>Autoimmun Rev</source>. <year>2012</year> <month>May</month>;<volume>11</volume>(<issue>6-7</issue>):<fpage>A544</fpage>–<lpage>54</lpage>. <pub-id pub-id-type="doi">10.1016/j.autrev.2012.01.003</pub-id><pub-id pub-id-type="pmid">22285588</pub-id><issn>1568-9972</issn></mixed-citation></ref>
<ref id="b4"><mixed-citation publication-type="journal" specific-use="restruct"><person-group person-group-type="author"><string-name><surname>Jennette</surname> <given-names>JC</given-names></string-name>, <string-name><surname>Falk</surname> <given-names>RJ</given-names></string-name>, <string-name><surname>Bacon</surname> <given-names>PA</given-names></string-name>, <string-name><surname>Basu</surname> <given-names>N</given-names></string-name>, <string-name><surname>Cid</surname> <given-names>MC</given-names></string-name>, <string-name><surname>Ferrario</surname> <given-names>F</given-names></string-name>, <etal>et al.</etal></person-group> <article-title>2012 revised International Chapel Hill Consensus Conference Nomenclature of Vasculitides</article-title>. <source>Arthritis Rheum</source>. <year>2013</year> <month>Jan</month>;<volume>65</volume>(<issue>1</issue>):<fpage>1</fpage>–<lpage>11</lpage>. <pub-id pub-id-type="doi">10.1002/art.37715</pub-id><pub-id pub-id-type="pmid">23045170</pub-id><issn>0004-3591</issn></mixed-citation></ref>
<ref id="b5"><mixed-citation publication-type="journal" specific-use="restruct"><person-group person-group-type="author"><string-name><surname>Ness</surname> <given-names>T</given-names></string-name>, <string-name><surname>Bley</surname> <given-names>TA</given-names></string-name>, <string-name><surname>Schmidt</surname> <given-names>WA</given-names></string-name>, <string-name><surname>Lamprecht</surname> <given-names>P</given-names></string-name></person-group>. <article-title>The diagnosis and treatment of giant cell arteritis</article-title>. <source>Dtsch Arztebl Int</source>. <year>2013</year> <month>May</month>;<volume>110</volume>(<issue>21</issue>):<fpage>376</fpage>–<lpage>85</lpage>.<pub-id pub-id-type="pmid">23795218</pub-id><issn>1866-0452</issn></mixed-citation></ref>
<ref id="b6"><mixed-citation publication-type="book-chapter" specific-use="linked"><person-group person-group-type="author"><string-name><surname>Nesher</surname> <given-names>G</given-names></string-name></person-group>. <chapter-title>Giant cell arteritis.</chapter-title> In: (eds.) YSea, editor. Diagnostic Criteria in Autoimmune Diseases. Totowa NJ: Humana Press; <year>2008</year>. p. 73–6. <pub-id pub-id-type="doi">10.1007/978-1-60327-285-8_13</pub-id><annotation><p content-type="warning">Edifix Bibliographic Reference Processing failed to fully style this reference. Please check the copyediting. (Ref. "Nesher, 2008")</p></annotation></mixed-citation></ref>
<ref id="b7"><mixed-citation publication-type="web-page" specific-use="unparsed">The Incidence Rate of Giant Cell Arteritis in Slovenia [Internet]. <year>2015</year> [cited August 11. 2016]. Available from: <ext-link ext-link-type="uri" xlink:href="http://acrabstracts.org/abstract/the-incidence-rate-of-giant-cell-arteritis-in-slovenia/">http://acrabstracts.org/abstract/the-incidence-rate-of-giant-cell-arteritis-in-slovenia/</ext-link></mixed-citation></ref>
<ref id="b8"><mixed-citation publication-type="journal" specific-use="restruct"><person-group person-group-type="author"><string-name><surname>Weyand</surname> <given-names>CM</given-names></string-name>, <string-name><surname>Goronzy</surname> <given-names>JJ</given-names></string-name></person-group>. <article-title>Giant-cell arteritis and polymyalgia rheumatica</article-title>. <source>N Engl J Med</source>. <year>2014</year> <month>Oct</month>;<volume>371</volume>(<issue>17</issue>):<fpage>1653</fpage>.<pub-id pub-id-type="pmid">25337759</pub-id><issn>1533-4406</issn></mixed-citation></ref>
<ref id="b9"><mixed-citation publication-type="unknown" specific-use="linked"><person-group person-group-type="author"><string-name><surname>Dejaco</surname> <given-names>C</given-names></string-name>, <string-name><surname>Duftner</surname> <given-names>C</given-names></string-name>, <string-name><surname>Buttgereit</surname> <given-names>F</given-names></string-name>, <string-name><surname>Matteson</surname> <given-names>EL</given-names></string-name>, <string-name><surname>Dasgupta</surname> <given-names>B</given-names></string-name></person-group>. <article-title>The spectrum of giant cell arteritis and polymyalgia rheumatica: revisiting the concept of the disease.</article-title> Rheumatology (Oxford). <year>2016</year>. <pub-id pub-id-type="doi">10.1093/rheumatology/kew273</pub-id></mixed-citation></ref>
<ref id="b10"><mixed-citation publication-type="journal" specific-use="restruct"><person-group person-group-type="author"><string-name><surname>Bienvenu</surname> <given-names>B</given-names></string-name>, <string-name><surname>Ly</surname> <given-names>KH</given-names></string-name>, <string-name><surname>Lambert</surname> <given-names>M</given-names></string-name>, <string-name><surname>Agard</surname> <given-names>C</given-names></string-name>, <string-name><surname>André</surname> <given-names>M</given-names></string-name>, <string-name><surname>Benhamou</surname> <given-names>Y</given-names></string-name>, <etal>et al.</etal>; <collab>Groupe d’Étude Français des Artérites des gros Vaisseaux, under the Aegis of the Filière des Maladies Auto-Immunes et Auto-Inflammatoires Rares</collab></person-group>. <article-title>Management of giant cell arteritis: Recommendations of the French Study Group for Large Vessel Vasculitis (GEFA)</article-title>. <source>Rev Med Interne</source>. <year>2016</year> <month>Mar</month>;<volume>37</volume>(<issue>3</issue>):<fpage>154</fpage>–<lpage>65</lpage>. <pub-id pub-id-type="doi">10.1016/j.revmed.2015.12.015</pub-id><pub-id pub-id-type="pmid">26833145</pub-id><issn>0248-8663</issn></mixed-citation></ref>
<ref id="b11"><mixed-citation publication-type="journal" specific-use="restruct"><person-group person-group-type="author"><string-name><surname>Liozon</surname> <given-names>E</given-names></string-name>, <string-name><surname>Ly</surname> <given-names>KH</given-names></string-name>, <string-name><surname>Robert</surname> <given-names>PY</given-names></string-name></person-group>. <article-title>[Ocular complications of giant cell arteritis]</article-title>. <source>Rev Med Interne</source>. <year>2013</year> <month>Jul</month>;<volume>34</volume>(<issue>7</issue>):<fpage>421</fpage>–<lpage>30</lpage>. <pub-id pub-id-type="doi">10.1016/j.revmed.2013.02.030</pub-id><pub-id pub-id-type="pmid">23523078</pub-id><issn>0248-8663</issn><annotation><p content-type="warning">PubMed reports the vernacular (French) article title is <underline>Manifestations ophtalmologiques de la maladie de Horton.</underline>. (Ref. "Liozon, Ly, Robert, 2013")</p></annotation></mixed-citation></ref>
<ref id="b12"><mixed-citation publication-type="journal" specific-use="restruct"><person-group person-group-type="author"><string-name><surname>González-Gay</surname> <given-names>MA</given-names></string-name>, <string-name><surname>García-Porrúa</surname> <given-names>C</given-names></string-name>, <string-name><surname>Llorca</surname> <given-names>J</given-names></string-name>, <string-name><surname>Hajeer</surname> <given-names>AH</given-names></string-name>, <string-name><surname>Brañas</surname> <given-names>F</given-names></string-name>, <string-name><surname>Dababneh</surname> <given-names>A</given-names></string-name>, <etal>et al.</etal></person-group> <article-title>Visual manifestations of giant cell arteritis. Trends and clinical spectrum in 161 patients</article-title>. <source>Medicine (Baltimore)</source>. <year>2000</year> <month>Sep</month>;<volume>79</volume>(<issue>5</issue>):<fpage>283</fpage>–<lpage>92</lpage>. <pub-id pub-id-type="doi">10.1097/00005792-200009000-00001</pub-id><pub-id pub-id-type="pmid">11039076</pub-id><issn>0025-7974</issn></mixed-citation></ref>
<ref id="b13"><mixed-citation publication-type="journal" specific-use="restruct"><person-group person-group-type="author"><string-name><surname>González-Gay</surname> <given-names>MA</given-names></string-name>, <string-name><surname>Blanco</surname> <given-names>R</given-names></string-name>, <string-name><surname>Rodríguez-Valverde</surname> <given-names>V</given-names></string-name>, <string-name><surname>Martínez-Taboada</surname> <given-names>VM</given-names></string-name>, <string-name><surname>Delgado-Rodriguez</surname> <given-names>M</given-names></string-name>, <string-name><surname>Figueroa</surname> <given-names>M</given-names></string-name>, <etal>et al.</etal></person-group> <article-title>Permanent visual loss and cerebrovascular accidents in giant cell arteritis: predictors and response to treatment</article-title>. <source>Arthritis Rheum</source>. <year>1998</year> <month>Aug</month>;<volume>41</volume>(<issue>8</issue>):<fpage>1497</fpage>–<lpage>504</lpage>. <pub-id pub-id-type="doi">10.1002/1529-0131(199808)41:8&lt;1497::AID-ART22&gt;3.0.CO;2-Z</pub-id><pub-id pub-id-type="pmid">9704651</pub-id><issn>0004-3591</issn></mixed-citation></ref>
<ref id="b14"><mixed-citation publication-type="journal" specific-use="restruct"><person-group person-group-type="author"><string-name><surname>Salvarani</surname> <given-names>C</given-names></string-name>, <string-name><surname>Della Bella</surname> <given-names>C</given-names></string-name>, <string-name><surname>Cimino</surname> <given-names>L</given-names></string-name>, <string-name><surname>Macchioni</surname> <given-names>P</given-names></string-name>, <string-name><surname>Formisano</surname> <given-names>D</given-names></string-name>, <string-name><surname>Bajocchi</surname> <given-names>G</given-names></string-name>, <etal>et al.</etal></person-group> <article-title>Risk factors for severe cranial ischaemic events in an Italian population-based cohort of patients with giant cell arteritis</article-title>. <source>Rheumatology (Oxford)</source>. <year>2009</year> <month>Mar</month>;<volume>48</volume>(<issue>3</issue>):<fpage>250</fpage>–<lpage>3</lpage>. <pub-id pub-id-type="doi">10.1093/rheumatology/ken465</pub-id><pub-id pub-id-type="pmid">19109317</pub-id><issn>1462-0324</issn></mixed-citation></ref>
<ref id="b15"><mixed-citation publication-type="journal" specific-use="restruct"><person-group person-group-type="author"><string-name><surname>Ninan</surname> <given-names>J</given-names></string-name>, <string-name><surname>Lester</surname> <given-names>S</given-names></string-name>, <string-name><surname>Hill</surname> <given-names>C</given-names></string-name></person-group>. <article-title>Giant cell arteritis</article-title>. <source>Best Pract Res Clin Rheumatol</source>. <year>2016</year> <month>Feb</month>;<volume>30</volume>(<issue>1</issue>):<fpage>169</fpage>–<lpage>88</lpage>. <pub-id pub-id-type="doi">10.1016/j.berh.2016.05.001</pub-id><pub-id pub-id-type="pmid">27421223</pub-id><issn>1521-6942</issn></mixed-citation></ref>
<ref id="b16"><mixed-citation publication-type="journal" specific-use="restruct"><person-group person-group-type="author"><string-name><surname>Salvarani</surname> <given-names>C</given-names></string-name>, <string-name><surname>Gabriel</surname> <given-names>SE</given-names></string-name>, <string-name><surname>O’Fallon</surname> <given-names>WM</given-names></string-name>, <string-name><surname>Hunder</surname> <given-names>GG</given-names></string-name></person-group>. <article-title>Epidemiology of polymyalgia rheumatica in Olmsted County, Minnesota, 1970-1991</article-title>. <source>Arthritis Rheum</source>. <year>1995</year> <month>Mar</month>;<volume>38</volume>(<issue>3</issue>):<fpage>369</fpage>–<lpage>73</lpage>. <pub-id pub-id-type="doi">10.1002/art.1780380311</pub-id><pub-id pub-id-type="pmid">7880191</pub-id><issn>0004-3591</issn></mixed-citation></ref>
<ref id="b17"><mixed-citation publication-type="journal" specific-use="restruct"><person-group person-group-type="author"><string-name><surname>Gran</surname> <given-names>JT</given-names></string-name>, <string-name><surname>Myklebust</surname> <given-names>G</given-names></string-name>, <string-name><surname>Wilsgaard</surname> <given-names>T</given-names></string-name>, <string-name><surname>Jacobsen</surname> <given-names>BK</given-names></string-name></person-group>. <article-title>Survival in polymyalgia rheumatica and temporal arteritis: a study of 398 cases and matched population controls</article-title>. <source>Rheumatology (Oxford)</source>. <year>2001</year> <month>Nov</month>;<volume>40</volume>(<issue>11</issue>):<fpage>1238</fpage>–<lpage>42</lpage>. <pub-id pub-id-type="doi">10.1093/rheumatology/40.11.1238</pub-id><pub-id pub-id-type="pmid">11709607</pub-id><issn>1462-0324</issn></mixed-citation></ref>
<ref id="b18"><mixed-citation publication-type="journal" specific-use="restruct"><person-group person-group-type="author"><string-name><surname>Gonzalez-Gay</surname> <given-names>MA</given-names></string-name>, <string-name><surname>Barros</surname> <given-names>S</given-names></string-name>, <string-name><surname>Lopez-Diaz</surname> <given-names>MJ</given-names></string-name>, <string-name><surname>Garcia-Porrua</surname> <given-names>C</given-names></string-name>, <string-name><surname>Sanchez-Andrade</surname> <given-names>A</given-names></string-name>, <string-name><surname>Llorca</surname> <given-names>J</given-names></string-name></person-group>. <article-title>Giant cell arteritis: disease patterns of clinical presentation in a series of 240 patients</article-title>. <source>Medicine (Baltimore)</source>. <year>2005</year> <month>Sep</month>;<volume>84</volume>(<issue>5</issue>):<fpage>269</fpage>–<lpage>76</lpage>. <pub-id pub-id-type="doi">10.1097/01.md.0000180042.42156.d1</pub-id><pub-id pub-id-type="pmid">16148727</pub-id><issn>0025-7974</issn></mixed-citation></ref>
<ref id="b19"><mixed-citation publication-type="journal" specific-use="restruct"><person-group person-group-type="author"><string-name><surname>Hunder</surname> <given-names>GG</given-names></string-name>, <string-name><surname>Bloch</surname> <given-names>DA</given-names></string-name>, <string-name><surname>Michel</surname> <given-names>BA</given-names></string-name>, <string-name><surname>Stevens</surname> <given-names>MB</given-names></string-name>, <string-name><surname>Arend</surname> <given-names>WP</given-names></string-name>, <string-name><surname>Calabrese</surname> <given-names>LH</given-names></string-name>, <etal>et al.</etal></person-group> <article-title>The American College of Rheumatology 1990 criteria for the classification of giant cell arteritis</article-title>. <source>Arthritis Rheum</source>. <year>1990</year> <month>Aug</month>;<volume>33</volume>(<issue>8</issue>):<fpage>1122</fpage>–<lpage>8</lpage>. <pub-id pub-id-type="doi">10.1002/art.1780330810</pub-id><pub-id pub-id-type="pmid">2202311</pub-id><issn>0004-3591</issn></mixed-citation></ref>
<ref id="b20"><mixed-citation publication-type="journal" specific-use="restruct"><person-group person-group-type="author"><string-name><surname>Nesher</surname> <given-names>G</given-names></string-name></person-group>. <article-title>The diagnosis and classification of giant cell arteritis</article-title>. <source>J Autoimmun</source>. <year>2014</year> <month>Feb-Mar</month>;<volume>48-49</volume>:<fpage>73</fpage>–<lpage>5</lpage>. <pub-id pub-id-type="doi">10.1016/j.jaut.2014.01.017</pub-id><pub-id pub-id-type="pmid">24461386</pub-id><issn>0896-8411</issn><annotation><p content-type="warning">Edifix has not found an issue number in the journal reference. Please check the volume/issue information. (Ref. "Nesher, 2014")</p></annotation></mixed-citation></ref>
<ref id="b21"><mixed-citation publication-type="journal" specific-use="restruct"><person-group person-group-type="author"><string-name><surname>Luqmani</surname> <given-names>R</given-names></string-name>, <string-name><surname>Lee</surname> <given-names>E</given-names></string-name>, <string-name><surname>Singh</surname> <given-names>S</given-names></string-name>, <string-name><surname>Gillett</surname> <given-names>M</given-names></string-name>, <string-name><surname>Schmidt</surname> <given-names>WA</given-names></string-name>, <string-name><surname>Bradburn</surname> <given-names>M</given-names></string-name>, <etal>et al.</etal></person-group> <article-title>The Role of Ultrasound Compared to Biopsy of Temporal Arteries in the Diagnosis and Treatment of Giant Cell Arteritis (TABUL): a diagnostic accuracy and cost-effectiveness study</article-title>. <source>Health Technol Assess</source>. <year>2016</year> <month>Nov</month>;<volume>20</volume>(<issue>90</issue>):<fpage>1</fpage>–<lpage>238</lpage>. <pub-id pub-id-type="doi">10.3310/hta20900</pub-id><pub-id pub-id-type="pmid">27925577</pub-id><issn>1366-5278</issn></mixed-citation></ref>
<ref id="b22"><mixed-citation publication-type="journal" specific-use="restruct"><person-group person-group-type="author"><string-name><surname>Schmidt</surname> <given-names>WA</given-names></string-name></person-group>. <article-title>Role of ultrasound in the understanding and management of vasculitis</article-title>. <source>Ther Adv Musculoskelet Dis</source>. <year>2014</year> <month>Apr</month>;<volume>6</volume>(<issue>2</issue>):<fpage>39</fpage>–<lpage>47</lpage>. <pub-id pub-id-type="doi">10.1177/1759720X13512256</pub-id><pub-id pub-id-type="pmid">24688604</pub-id><issn>1759-720X</issn></mixed-citation></ref>
<ref id="b23"><mixed-citation publication-type="journal" specific-use="restruct"><person-group person-group-type="author"><string-name><surname>Lee</surname> <given-names>YH</given-names></string-name>, <string-name><surname>Choi</surname> <given-names>SJ</given-names></string-name>, <string-name><surname>Ji</surname> <given-names>JD</given-names></string-name>, <string-name><surname>Song</surname> <given-names>GG</given-names></string-name></person-group>. <article-title>Diagnostic accuracy of 18F-FDG PET or PET/CT for large vessel vasculitis : A meta-analysis</article-title>. <source>Z Rheumatol</source>. <year>2016</year> <month>Nov</month>;<volume>75</volume>(<issue>9</issue>):<fpage>924</fpage>–<lpage>31</lpage>. <pub-id pub-id-type="doi">10.1007/s00393-015-1674-2</pub-id><pub-id pub-id-type="pmid">26704559</pub-id><issn>0340-1855</issn><annotation><p content-type="warning">PubMed reports the vernacular (English) article title is <underline>Diagnostische Genauigkeit der 18F-FDG PET bzw. PET/CT für Vaskulitiden großer Gefäße : Eine Metaanalyse.</underline>. (Ref. "Lee, Choi, Ji, Song, 2016")</p></annotation></mixed-citation></ref>
<ref id="b24"><mixed-citation publication-type="journal" specific-use="restruct"><person-group person-group-type="author"><string-name><surname>Hocevar</surname> <given-names>A</given-names></string-name>, <string-name><surname>Rotar</surname> <given-names>Z</given-names></string-name>, <string-name><surname>Jese</surname> <given-names>R</given-names></string-name>, <string-name><surname>Semrl</surname> <given-names>SS</given-names></string-name>, <string-name><surname>Pizem</surname> <given-names>J</given-names></string-name>, <string-name><surname>Hawlina</surname> <given-names>M</given-names></string-name>, <etal>et al.</etal></person-group> <article-title>Do Early Diagnosis and Glucocorticoid Treatment Decrease the Risk of Permanent Visual Loss and Early Relapses in Giant Cell Arteritis: A Prospective Longitudinal Study</article-title>. <source>Medicine (Baltimore)</source>. <year>2016</year> <month>Apr</month>;<volume>95</volume>(<issue>14</issue>):<fpage>e3210</fpage>. <pub-id pub-id-type="doi">10.1097/MD.0000000000003210</pub-id><pub-id pub-id-type="pmid">27057850</pub-id><issn>0025-7974</issn></mixed-citation></ref>
<ref id="b25"><mixed-citation publication-type="journal" specific-use="restruct"><person-group person-group-type="author"><string-name><surname>Unizony</surname> <given-names>SH</given-names></string-name>, <string-name><surname>Dasgupta</surname> <given-names>B</given-names></string-name>, <string-name><surname>Fisheleva</surname> <given-names>E</given-names></string-name>, <string-name><surname>Rowell</surname> <given-names>L</given-names></string-name>, <string-name><surname>Schett</surname> <given-names>G</given-names></string-name>, <string-name><surname>Spiera</surname> <given-names>R</given-names></string-name>, <etal>et al.</etal></person-group> <article-title>Design of the tocilizumab in giant cell arteritis trial</article-title>. <source>Int J Rheumatol</source>. <year>2013</year>;<volume>2013</volume>:<fpage>912562</fpage>. <pub-id pub-id-type="doi">10.1155/2013/912562</pub-id><pub-id pub-id-type="pmid">23653652</pub-id><issn>1687-9260</issn><annotation><p content-type="warning">Edifix has not found an issue number in the journal reference. Please check the volume/issue information. (Ref. "Unizony, Dasgupta, Fisheleva, Rowell, Schett, Spiera, et al., 2013")</p></annotation></mixed-citation></ref>
<ref id="b26"><mixed-citation publication-type="journal" specific-use="restruct"><person-group person-group-type="author"><string-name><surname>Mukhtyar</surname> <given-names>C</given-names></string-name>, <string-name><surname>Guillevin</surname> <given-names>L</given-names></string-name>, <string-name><surname>Cid</surname> <given-names>MC</given-names></string-name>, <string-name><surname>Dasgupta</surname> <given-names>B</given-names></string-name>, <string-name><surname>de Groot</surname> <given-names>K</given-names></string-name>, <string-name><surname>Gross</surname> <given-names>W</given-names></string-name>, <etal>et al.</etal>; <collab>European Vasculitis Study Group</collab></person-group>. <article-title>EULAR recommendations for the management of large vessel vasculitis</article-title>. <source>Ann Rheum Dis</source>. <year>2009</year> <month>Mar</month>;<volume>68</volume>(<issue>3</issue>):<fpage>318</fpage>–<lpage>23</lpage>. <pub-id pub-id-type="doi">10.1136/ard.2008.088351</pub-id><pub-id pub-id-type="pmid">18413441</pub-id><issn>0003-4967</issn></mixed-citation></ref>
<ref id="b27"><mixed-citation publication-type="journal" specific-use="restruct"><person-group person-group-type="author"><string-name><surname>Hoffman</surname> <given-names>GS</given-names></string-name>, <string-name><surname>Cid</surname> <given-names>MC</given-names></string-name>, <string-name><surname>Hellmann</surname> <given-names>DB</given-names></string-name>, <string-name><surname>Guillevin</surname> <given-names>L</given-names></string-name>, <string-name><surname>Stone</surname> <given-names>JH</given-names></string-name>, <string-name><surname>Schousboe</surname> <given-names>J</given-names></string-name>, <etal>et al.</etal>; <collab>International Network for the Study of Systemic Vasculitides</collab></person-group>. <article-title>A multicenter, randomized, double-blind, placebo-controlled trial of adjuvant methotrexate treatment for giant cell arteritis</article-title>. <source>Arthritis Rheum</source>. <year>2002</year> <month>May</month>;<volume>46</volume>(<issue>5</issue>):<fpage>1309</fpage>–<lpage>18</lpage>. <pub-id pub-id-type="doi">10.1002/art.10262</pub-id><pub-id pub-id-type="pmid">12115238</pub-id><issn>0004-3591</issn></mixed-citation></ref>
<ref id="b28"><mixed-citation publication-type="unknown" specific-use="unparsed"><person-group person-group-type="author"><string-name><surname>Rodriguez Rodriguez</surname> <given-names>L</given-names></string-name>, <string-name><surname>Leon</surname> <given-names>L</given-names></string-name>, <string-name><surname>Morado</surname> <given-names>I</given-names></string-name>, <string-name><surname>Rosales Rosado</surname> <given-names>Z</given-names></string-name>, <string-name><surname>Vadillo Font</surname> <given-names>C</given-names></string-name></person-group> FND, Macarrón P, et al. Treatment with Methotrexate and Risk of Relapses in Patients with Giant Cell Arteritis in Clinical Practice [abstract]. Arthritis Rheumatol. <year>2016</year>;68 (suppl 10).</mixed-citation></ref>
<ref id="b29"><mixed-citation publication-type="unknown" specific-use="unparsed"><person-group person-group-type="author"><string-name><surname>Koster</surname> <given-names>MJ</given-names></string-name>, <string-name><surname>Crowson</surname> <given-names>CS</given-names></string-name>, <string-name><surname>Labarca</surname> <given-names>C</given-names></string-name>, <string-name><surname>Muratore</surname> <given-names>F</given-names></string-name></person-group>, KJ. W. Efficacy of Methotrexate in Giant Cell Arteritis [abstract]. Arthritis Rheumatol. <year>2016</year>;68 (suppl 10).</mixed-citation></ref>
<ref id="b30"><mixed-citation publication-type="journal" specific-use="restruct"><person-group person-group-type="author"><string-name><surname>Jover</surname> <given-names>JA</given-names></string-name>, <string-name><surname>Hernández-García</surname> <given-names>C</given-names></string-name>, <string-name><surname>Morado</surname> <given-names>IC</given-names></string-name>, <string-name><surname>Vargas</surname> <given-names>E</given-names></string-name>, <string-name><surname>Bañares</surname> <given-names>A</given-names></string-name>, <string-name><surname>Fernández-Gutiérrez</surname> <given-names>B</given-names></string-name></person-group>. <article-title>Combined treatment of giant-cell arteritis with methotrexate and prednisone. a randomized, double-blind, placebo-controlled trial</article-title>. <source>Ann Intern Med</source>. <year>2001</year> <month>Jan</month>;<volume>134</volume>(<issue>2</issue>):<fpage>106</fpage>–<lpage>14</lpage>. <pub-id pub-id-type="doi">10.7326/0003-4819-134-2-200101160-00010</pub-id><pub-id pub-id-type="pmid">11177313</pub-id><issn>0003-4819</issn></mixed-citation></ref>
<ref id="b31"><mixed-citation publication-type="journal" specific-use="restruct"><person-group person-group-type="author"><string-name><surname>Diamantopoulos</surname> <given-names>AP</given-names></string-name>, <string-name><surname>Hetland</surname> <given-names>H</given-names></string-name>, <string-name><surname>Myklebust</surname> <given-names>G</given-names></string-name></person-group>. <article-title>Leflunomide as a corticosteroid-sparing agent in giant cell arteritis and polymyalgia rheumatica: a case series</article-title>. <source>BioMed Res Int</source>. <year>2013</year>;<volume>2013</volume>:<fpage>120638</fpage>. <pub-id pub-id-type="doi">10.1155/2013/120638</pub-id><pub-id pub-id-type="pmid">24106691</pub-id><issn>2314-6133</issn><annotation><p content-type="warning">Edifix has not found an issue number in the journal reference. Please check the volume/issue information. (Ref. "Diamantopoulos, Hetland, Myklebust, 2013")</p></annotation></mixed-citation></ref>
<ref id="b32"><mixed-citation publication-type="journal" specific-use="restruct"><person-group person-group-type="author"><string-name><surname>Voelker</surname> <given-names>R</given-names></string-name></person-group>. <article-title>A First for Giant Cell Arteritis</article-title>. <source>JAMA</source>. <year>2017</year> <month>Jul</month>;<volume>318</volume>(<issue>1</issue>):<fpage>20</fpage>.<pub-id pub-id-type="pmid">28672299</pub-id><issn>1538-3598</issn></mixed-citation></ref>
<ref id="b33"><mixed-citation publication-type="web-page" specific-use="unparsed"><person-group person-group-type="author"><collab>FDA</collab></person-group>. <article-title>FDA approves first drug to specifically treat giant cell arteritis</article-title> <year>2017</year> [cited 2017 25 July 2017]. Available from: <ext-link ext-link-type="uri" xlink:href="https://www.fda.gov/newsevents/newsroom/pressannouncements/ucm559791.htm">https://www.fda.gov/newsevents/newsroom/pressannouncements/ucm559791.htm</ext-link></mixed-citation></ref>
<ref id="b34"><mixed-citation publication-type="journal" specific-use="restruct"><person-group person-group-type="author"><string-name><surname>Conway</surname> <given-names>R</given-names></string-name>, <string-name><surname>O’Neill</surname> <given-names>L</given-names></string-name>, <string-name><surname>O’Flynn</surname> <given-names>E</given-names></string-name>, <string-name><surname>Gallagher</surname> <given-names>P</given-names></string-name>, <string-name><surname>McCarthy</surname> <given-names>GM</given-names></string-name>, <string-name><surname>Murphy</surname> <given-names>CC</given-names></string-name>, <etal>et al.</etal></person-group> <article-title>Ustekinumab for the treatment of refractory giant cell arteritis</article-title>. <source>Ann Rheum Dis</source>. <year>2016</year> <month>Aug</month>;<volume>75</volume>(<issue>8</issue>):<fpage>1578</fpage>–<lpage>9</lpage>. <pub-id pub-id-type="doi">10.1136/annrheumdis-2016-209351</pub-id><pub-id pub-id-type="pmid">27143653</pub-id><issn>0003-4967</issn><annotation><p content-type="warning">Based on PubMed data, Edifix has added authors to this reference. The original author was "<underline>Conway</underline>". Please check carefully as this change may affect the in-text citations. (Ref. "Conway, O’Neill, O’Flynn, Gallagher, McCarthy, Murphy, et al., 2016")</p></annotation></mixed-citation></ref>
<ref id="b35"><mixed-citation publication-type="unknown" specific-use="unparsed"><person-group person-group-type="author"><string-name><surname>Conway</surname> <given-names>R</given-names></string-name></person-group>, O‘Neill L, Gallagher P, O‘Flynn E, McCarthy GM, Murphy C, et al. Long Term Efficacy of Ustekinumab for the Treatment of Giant Cell Arteritis [abstract]. Arthritis Rheumatol. <year>2016</year>;68 (suppl 10).</mixed-citation></ref>
<ref id="b36"><mixed-citation publication-type="journal" specific-use="restruct"><person-group person-group-type="author"><string-name><surname>Diamantopoulos</surname> <given-names>AP</given-names></string-name>, <string-name><surname>Haugeberg</surname> <given-names>G</given-names></string-name>, <string-name><surname>Lindland</surname> <given-names>A</given-names></string-name>, <string-name><surname>Myklebust</surname> <given-names>G</given-names></string-name></person-group>. <article-title>The fast-track ultrasound clinic for early diagnosis of giant cell arteritis significantly reduces permanent visual impairment: towards a more effective strategy to improve clinical outcome in giant cell arteritis?</article-title> <source>Rheumatology (Oxford)</source>. <year>2016</year> <month>Jan</month>;<volume>55</volume>(<issue>1</issue>):<fpage>66</fpage>–<lpage>70</lpage>. <pub-id pub-id-type="doi">10.1093/rheumatology/kev289</pub-id><pub-id pub-id-type="pmid">26286743</pub-id><issn>1462-0324</issn></mixed-citation></ref>
<ref id="b37"><mixed-citation publication-type="journal" specific-use="restruct"><person-group person-group-type="author"><string-name><surname>Carbonella</surname> <given-names>A</given-names></string-name>, <string-name><surname>Berardi</surname> <given-names>G</given-names></string-name>, <string-name><surname>Petricca</surname> <given-names>L</given-names></string-name>, <string-name><surname>Biscetti</surname> <given-names>F</given-names></string-name>, <string-name><surname>Alivernini</surname> <given-names>S</given-names></string-name>, <string-name><surname>Bosello</surname> <given-names>SL</given-names></string-name>, <etal>et al.</etal></person-group> <article-title>Immunosuppressive Therapy (Methotrexate or Cyclophosphamide) in Combination with Corticosteroids in the Treatment of Giant Cell Arteritis: Comparison with Corticosteroids Alone</article-title>. <source>J Am Geriatr Soc</source>. <year>2016</year> <month>Mar</month>;<volume>64</volume>(<issue>3</issue>):<fpage>672</fpage>–<lpage>374</lpage>. <pub-id pub-id-type="doi">10.1111/jgs.14004</pub-id><pub-id pub-id-type="pmid">27000356</pub-id><issn>0002-8614</issn></mixed-citation></ref>
<ref id="b38"><mixed-citation publication-type="journal" specific-use="restruct"><person-group person-group-type="author"><string-name><surname>Seelinger</surname> <given-names>B</given-names></string-name>, <string-name><surname>Sznajd</surname> <given-names>J</given-names></string-name>, <string-name><surname>Judge</surname> <given-names>A</given-names></string-name>, <string-name><surname>Robson</surname> <given-names>JC</given-names></string-name>, <string-name><surname>Craven</surname> <given-names>A</given-names></string-name>, <string-name><surname>Jayne</surname> <given-names>M</given-names></string-name>, <etal>et al.</etal></person-group> <article-title>Predictors of Delay in Diagnosis of Giant Cell Arteritis and Antineutrophil Cytoplasm Antibody Associated Vasculitides: Analysis of Data from the Diagnostic &amp; Classification Criteria in Vasculitis Study</article-title>. <source>Rheumatology</source>. <year>2015</year>;<volume>•••</volume>:<fpage>i172</fpage>–<lpage>3</lpage>.<issn>0080-2727</issn><annotation><p content-type="warning">The reference title appears to be set in title case rather than sentence case. (Ref. "Seelinger, Sznajd, Judge, Robson, Craven, Jayne, et al., 2015")</p><p content-type="warning">Please provide the missing volume number in this journal reference. (Ref. "Seelinger, Sznajd, Judge, Robson, Craven, Jayne, et al., 2015")</p><p content-type="warning">Edifix has not found an issue number in the journal reference. Please check the volume/issue information. (Ref. "Seelinger, Sznajd, Judge, Robson, Craven, Jayne, et al., 2015")</p></annotation></mixed-citation></ref>
<ref id="b39"><mixed-citation publication-type="journal" specific-use="restruct"><person-group person-group-type="author"><string-name><surname>Ezeonyeji</surname> <given-names>AN</given-names></string-name>, <string-name><surname>Borg</surname> <given-names>FA</given-names></string-name>, <string-name><surname>Dasgupta</surname> <given-names>B</given-names></string-name></person-group>. <article-title>Delays in recognition and management of giant cell arteritis: results from a retrospective audit</article-title>. <source>Clin Rheumatol</source>. <year>2011</year> <month>Feb</month>;<volume>30</volume>(<issue>2</issue>):<fpage>259</fpage>–<lpage>62</lpage>. <pub-id pub-id-type="doi">10.1007/s10067-010-1616-y</pub-id><pub-id pub-id-type="pmid">21086005</pub-id><issn>0770-3198</issn></mixed-citation></ref>
<ref id="b40"><mixed-citation publication-type="journal" specific-use="restruct"><person-group person-group-type="author"><string-name><surname>Chandran</surname> <given-names>AK</given-names></string-name>, <string-name><surname>Udayakumar</surname> <given-names>PD</given-names></string-name>, <string-name><surname>Crowson</surname> <given-names>CS</given-names></string-name>, <string-name><surname>Warrington</surname> <given-names>KJ</given-names></string-name>, <string-name><surname>Matteson</surname> <given-names>EL</given-names></string-name></person-group>. <article-title>The incidence of giant cell arteritis in Olmsted County, Minnesota, over a 60-year period 1950-2009</article-title>. <source>Scand J Rheumatol</source>. <year>2015</year> <month>May</month>;<volume>44</volume>(<issue>3</issue>):<fpage>215</fpage>–<lpage>8</lpage>. <pub-id pub-id-type="doi">10.3109/03009742.2014.982701</pub-id><pub-id pub-id-type="pmid">25606666</pub-id><issn>0300-9742</issn></mixed-citation></ref>
<ref id="b41"><mixed-citation publication-type="journal" specific-use="restruct"><person-group person-group-type="author"><string-name><surname>Baldini</surname> <given-names>M</given-names></string-name>, <string-name><surname>Maugeri</surname> <given-names>N</given-names></string-name>, <string-name><surname>Ramirez</surname> <given-names>GA</given-names></string-name>, <string-name><surname>Giacomassi</surname> <given-names>C</given-names></string-name>, <string-name><surname>Castiglioni</surname> <given-names>A</given-names></string-name>, <string-name><surname>Prieto-González</surname> <given-names>S</given-names></string-name>, <etal>et al.</etal></person-group> <article-title>Selective up-regulation of the soluble pattern-recognition receptor pentraxin 3 and of vascular endothelial growth factor in giant cell arteritis: relevance for recent optic nerve ischemia</article-title>. <source>Arthritis Rheum</source>. <year>2012</year> <month>Mar</month>;<volume>64</volume>(<issue>3</issue>):<fpage>854</fpage>–<lpage>65</lpage>. <pub-id pub-id-type="doi">10.1002/art.33411</pub-id><pub-id pub-id-type="pmid">21989653</pub-id><issn>0004-3591</issn></mixed-citation></ref>
<ref id="b42"><mixed-citation publication-type="journal" specific-use="restruct"><person-group person-group-type="author"><string-name><surname>Ciccia</surname> <given-names>F</given-names></string-name>, <string-name><surname>Rizzo</surname> <given-names>A</given-names></string-name>, <string-name><surname>Maugeri</surname> <given-names>R</given-names></string-name>, <string-name><surname>Alessandro</surname> <given-names>R</given-names></string-name>, <string-name><surname>Croci</surname> <given-names>S</given-names></string-name>, <string-name><surname>Guggino</surname> <given-names>G</given-names></string-name>, <etal>et al.</etal></person-group> <article-title>Ectopic expression of CXCL13, BAFF, APRIL and LT-β is associated with artery tertiary lymphoid organs in giant cell arteritis</article-title>. <source>Ann Rheum Dis</source>. <year>2016</year>;<volume>•••</volume>: <pub-id pub-id-type="doi">10.1136/annrheumdis-2016–209217</pub-id>; [<comment>Epub ahead of print</comment>].<pub-id pub-id-type="pmid">27098405</pub-id><issn>0003-4967</issn><annotation><p content-type="warning">Edifix has not updated this reference because the year and volume differ from the author original and the first page is missing. The PubMed reference is <underline>Ciccia F, Rizzo A, Maugeri R, Alessandro R, Croci S, Guggino G, et al. Ectopic expression of CXCL13, BAFF, APRIL and LT-β is associated with artery tertiary lymphoid organs in giant cell arteritis. Ann Rheum Dis. 2017 Jan;76(1):235–43</underline>. (Ref. "Ciccia, Rizzo, Maugeri, Alessandro, Croci, Guggino, et al., 2016")</p></annotation></mixed-citation></ref>
<ref id="b43"><mixed-citation publication-type="journal" specific-use="restruct"><person-group person-group-type="author"><string-name><surname>Labarca</surname> <given-names>C</given-names></string-name>, <string-name><surname>Koster</surname> <given-names>MJ</given-names></string-name>, <string-name><surname>Crowson</surname> <given-names>CS</given-names></string-name>, <string-name><surname>Makol</surname> <given-names>A</given-names></string-name>, <string-name><surname>Ytterberg</surname> <given-names>SR</given-names></string-name>, <string-name><surname>Matteson</surname> <given-names>EL</given-names></string-name>, <etal>et al.</etal></person-group> <article-title>Predictors of relapse and treatment outcomes in biopsy-proven giant cell arteritis: a retrospective cohort study</article-title>. <source>Rheumatology (Oxford)</source>. <year>2016</year> <month>Feb</month>;<volume>55</volume>(<issue>2</issue>):<fpage>347</fpage>–<lpage>56</lpage>. <pub-id pub-id-type="doi">10.1093/rheumatology/kev348</pub-id><pub-id pub-id-type="pmid">26385368</pub-id><issn>1462-0324</issn></mixed-citation></ref>
<ref id="b44"><mixed-citation publication-type="journal" specific-use="restruct"><person-group person-group-type="author"><string-name><surname>Muller</surname> <given-names>G</given-names></string-name>, <string-name><surname>Devilliers</surname> <given-names>H</given-names></string-name>, <string-name><surname>Besancenot</surname> <given-names>JF</given-names></string-name>, <string-name><surname>Manckoundia</surname> <given-names>P</given-names></string-name></person-group>. <article-title>Giant cell arteritis (Horton’s disease) in very elderly patients aged 80 years and older: A study of 25 cases</article-title>. <source>Geriatr Gerontol Int</source>. <year>2016</year> <month>Jun</month>;<volume>16</volume>(<issue>6</issue>):<fpage>679</fpage>–<lpage>85</lpage>. <pub-id pub-id-type="doi">10.1111/ggi.12536</pub-id><pub-id pub-id-type="pmid">26081629</pub-id><issn>1444-1586</issn></mixed-citation></ref>
<ref id="b45"><mixed-citation publication-type="journal" specific-use="restruct"><person-group person-group-type="author"><string-name><surname>Muratore</surname> <given-names>F</given-names></string-name>, <string-name><surname>Kermani</surname> <given-names>TA</given-names></string-name>, <string-name><surname>Crowson</surname> <given-names>CS</given-names></string-name>, <string-name><surname>Green</surname> <given-names>AB</given-names></string-name>, <string-name><surname>Salvarani</surname> <given-names>C</given-names></string-name>, <string-name><surname>Matteson</surname> <given-names>EL</given-names></string-name>, <etal>et al.</etal></person-group> <article-title>Large-vessel giant cell arteritis: a cohort study</article-title>. <source>Rheumatology (Oxford)</source>. <year>2015</year> <month>Mar</month>;<volume>54</volume>(<issue>3</issue>):<fpage>463</fpage>–<lpage>70</lpage>. <pub-id pub-id-type="doi">10.1093/rheumatology/keu329</pub-id><pub-id pub-id-type="pmid">25193809</pub-id><issn>1462-0324</issn></mixed-citation></ref>
<ref id="b46"><mixed-citation publication-type="journal" specific-use="restruct"><person-group person-group-type="author"><string-name><surname>Alba</surname> <given-names>MA</given-names></string-name>, <string-name><surname>Mena-Madrazo</surname> <given-names>JA</given-names></string-name>, <string-name><surname>Reyes</surname> <given-names>E</given-names></string-name>, <string-name><surname>Flores-Suárez</surname> <given-names>LF</given-names></string-name></person-group>. <article-title>Giant cell arteritis in Mexican patients</article-title>. <source>J Clin Rheumatol</source>. <year>2012</year> <month>Jan</month>;<volume>18</volume>(<issue>1</issue>):<fpage>1</fpage>–<lpage>7</lpage>. <pub-id pub-id-type="doi">10.1097/RHU.0b013e31823e2e35</pub-id><pub-id pub-id-type="pmid">22157266</pub-id><issn>1076-1608</issn></mixed-citation></ref>
<ref id="b47"><mixed-citation publication-type="journal" specific-use="restruct"><person-group person-group-type="author"><string-name><surname>Alba</surname> <given-names>MA</given-names></string-name>, <string-name><surname>García-Martínez</surname> <given-names>A</given-names></string-name>, <string-name><surname>Prieto-González</surname> <given-names>S</given-names></string-name>, <string-name><surname>Tavera-Bahillo</surname> <given-names>I</given-names></string-name>, <string-name><surname>Corbera-Bellalta</surname> <given-names>M</given-names></string-name>, <string-name><surname>Planas-Rigol</surname> <given-names>E</given-names></string-name>, <etal>et al.</etal></person-group> <article-title>Relapses in patients with giant cell arteritis: prevalence, characteristics, and associated clinical findings in a longitudinally followed cohort of 106 patients</article-title>. <source>Medicine (Baltimore)</source>. <year>2014</year> <month>Jul</month>;<volume>93</volume>(<issue>5</issue>):<fpage>194</fpage>–<lpage>201</lpage>. <pub-id pub-id-type="doi">10.1097/MD.0000000000000033</pub-id><pub-id pub-id-type="pmid">25181312</pub-id><issn>0025-7974</issn></mixed-citation></ref>
<ref id="b48"><mixed-citation publication-type="journal" specific-use="restruct"><person-group person-group-type="author"><string-name><surname>Singh</surname> <given-names>AG</given-names></string-name>, <string-name><surname>Kermani</surname> <given-names>TA</given-names></string-name>, <string-name><surname>Crowson</surname> <given-names>CS</given-names></string-name>, <string-name><surname>Weyand</surname> <given-names>CM</given-names></string-name>, <string-name><surname>Matteson</surname> <given-names>EL</given-names></string-name>, <string-name><surname>Warrington</surname> <given-names>KJ</given-names></string-name></person-group>. <article-title>Visual manifestations in giant cell arteritis: trend over 5 decades in a population-based cohort</article-title>. <source>J Rheumatol</source>. <year>2015</year> <month>Feb</month>;<volume>42</volume>(<issue>2</issue>):<fpage>309</fpage>–<lpage>15</lpage>. <pub-id pub-id-type="doi">10.3899/jrheum.140188</pub-id><pub-id pub-id-type="pmid">25512481</pub-id><issn>0315-162X</issn></mixed-citation></ref>
<ref id="b49"><mixed-citation publication-type="journal" specific-use="restruct"><person-group person-group-type="author"><string-name><surname>Gonzalez-Gay</surname> <given-names>MA</given-names></string-name>, <string-name><surname>Miranda-Filloy</surname> <given-names>JA</given-names></string-name>, <string-name><surname>Lopez-Diaz</surname> <given-names>MJ</given-names></string-name>, <string-name><surname>Perez-Alvarez</surname> <given-names>R</given-names></string-name>, <string-name><surname>Gonzalez-Juanatey</surname> <given-names>C</given-names></string-name>, <string-name><surname>Sanchez-Andrade</surname> <given-names>A</given-names></string-name>, <etal>et al.</etal></person-group> <article-title>Giant cell arteritis in northwestern Spain: a 25-year epidemiologic study</article-title>. <source>Medicine (Baltimore)</source>. <year>2007</year> <month>Mar</month>;<volume>86</volume>(<issue>2</issue>):<fpage>61</fpage>–<lpage>8</lpage>. <pub-id pub-id-type="doi">10.1097/md.0b013e31803d1764</pub-id><pub-id pub-id-type="pmid">17435586</pub-id><issn>0025-7974</issn></mixed-citation></ref>
<ref id="b50"><mixed-citation publication-type="journal" specific-use="restruct"><person-group person-group-type="author"><string-name><surname>Gonzalez-Gay</surname> <given-names>MA</given-names></string-name>, <string-name><surname>Castañeda</surname> <given-names>S</given-names></string-name>, <string-name><surname>Llorca</surname> <given-names>J</given-names></string-name></person-group>. <article-title>Giant Cell Arteritis: Visual Loss Is Our Major Concern</article-title>. <source>J Rheumatol</source>. <year>2016</year> <month>Aug</month>;<volume>43</volume>(<issue>8</issue>):<fpage>1458</fpage>–<lpage>61</lpage>. <pub-id pub-id-type="doi">10.3899/jrheum.160466</pub-id><pub-id pub-id-type="pmid">27481989</pub-id><issn>0315-162X</issn></mixed-citation></ref>
<ref id="b51"><mixed-citation publication-type="conference" specific-use="unparsed"><person-group person-group-type="editor"><string-name><surname>Žigon</surname> <given-names>P</given-names></string-name>, <string-name><surname>Lakota</surname> <given-names>K</given-names></string-name>, <string-name><surname>Kuret</surname> <given-names>T</given-names></string-name>, <string-name><surname>Tomšič</surname> <given-names>M</given-names></string-name>, <string-name><surname>Čučnik</surname> <given-names>S</given-names></string-name>, <string-name><surname>Sodin-Šemrl</surname> <given-names>S</given-names></string-name>, <etal>et al.</etal>, <role>editors</role></person-group>. Acute Phase Proteins and Interleukin-6 are Important in Distinguishing between Giant Cell Arteritis Positive and Negative Patients. 10th international congress on autoimmunity; <year>2016</year>; Leipzig: Autoimmunity.</mixed-citation></ref>
<ref id="b52"><mixed-citation publication-type="journal" specific-use="restruct"><person-group person-group-type="author"><string-name><surname>Deng</surname> <given-names>J</given-names></string-name>, <string-name><surname>Younge</surname> <given-names>BR</given-names></string-name>, <string-name><surname>Olshen</surname> <given-names>RA</given-names></string-name>, <string-name><surname>Goronzy</surname> <given-names>JJ</given-names></string-name>, <string-name><surname>Weyand</surname> <given-names>CM</given-names></string-name></person-group>. <article-title>Th17 and Th1 T-cell responses in giant cell arteritis</article-title>. <source>Circulation</source>. <year>2010</year> <month>Feb</month>;<volume>121</volume>(<issue>7</issue>):<fpage>906</fpage>–<lpage>15</lpage>. <pub-id pub-id-type="doi">10.1161/CIRCULATIONAHA.109.872903</pub-id><pub-id pub-id-type="pmid">20142449</pub-id><issn>0009-7322</issn></mixed-citation></ref>
<ref id="b53"><mixed-citation publication-type="journal" specific-use="restruct"><person-group person-group-type="author"><string-name><surname>Hernández-Rodríguez</surname> <given-names>J</given-names></string-name>, <string-name><surname>García-Martínez</surname> <given-names>A</given-names></string-name>, <string-name><surname>Casademont</surname> <given-names>J</given-names></string-name>, <string-name><surname>Filella</surname> <given-names>X</given-names></string-name>, <string-name><surname>Esteban</surname> <given-names>MJ</given-names></string-name>, <string-name><surname>López-Soto</surname> <given-names>A</given-names></string-name>, <etal>et al.</etal></person-group> <article-title>A strong initial systemic inflammatory response is associated with higher corticosteroid requirements and longer duration of therapy in patients with giant-cell arteritis</article-title>. <source>Arthritis Rheum</source>. <year>2002</year> <month>Feb</month>;<volume>47</volume>(<issue>1</issue>):<fpage>29</fpage>–<lpage>35</lpage>. <pub-id pub-id-type="doi">10.1002/art1.10161</pub-id><pub-id pub-id-type="pmid">11932875</pub-id><issn>0004-3591</issn></mixed-citation></ref>
<ref id="b54"><mixed-citation publication-type="journal" specific-use="restruct"><person-group person-group-type="author"><string-name><surname>Roblot</surname> <given-names>P</given-names></string-name>, <string-name><surname>Morel</surname> <given-names>F</given-names></string-name>, <string-name><surname>Lelievre</surname> <given-names>E</given-names></string-name>, <string-name><surname>Gascan</surname> <given-names>H</given-names></string-name>, <string-name><surname>Wijdenes</surname> <given-names>J</given-names></string-name>, <string-name><surname>Lecron</surname> <given-names>JC</given-names></string-name></person-group>. <article-title>Serum cytokine and cytokine receptor levels in patients with giant cell arteritis during corticotherapy</article-title>. <source>J Rheumatol</source>. <year>1996</year> <month>Feb</month>;<volume>23</volume>(<issue>2</issue>):<fpage>408</fpage>–<lpage>10</lpage>.<pub-id pub-id-type="pmid">8882065</pub-id><issn>0315-162X</issn></mixed-citation></ref>
<ref id="b55"><mixed-citation publication-type="journal" specific-use="restruct"><person-group person-group-type="author"><string-name><surname>Emilie</surname> <given-names>D</given-names></string-name>, <string-name><surname>Liozon</surname> <given-names>E</given-names></string-name>, <string-name><surname>Crevon</surname> <given-names>MC</given-names></string-name>, <string-name><surname>Lavignac</surname> <given-names>C</given-names></string-name>, <string-name><surname>Portier</surname> <given-names>A</given-names></string-name>, <string-name><surname>Liozon</surname> <given-names>F</given-names></string-name>, <etal>et al.</etal></person-group> <article-title>Production of interleukin 6 by granulomas of giant cell arteritis</article-title>. <source>Hum Immunol</source>. <year>1994</year> <month>Jan</month>;<volume>39</volume>(<issue>1</issue>):<fpage>17</fpage>–<lpage>24</lpage>. <pub-id pub-id-type="doi">10.1016/0198-8859(94)90096-5</pub-id><pub-id pub-id-type="pmid">8181959</pub-id><issn>0198-8859</issn></mixed-citation></ref>
<ref id="b56"><mixed-citation publication-type="journal" specific-use="restruct"><person-group person-group-type="author"><string-name><surname>Lecron</surname> <given-names>JC</given-names></string-name>, <string-name><surname>Roblot</surname> <given-names>P</given-names></string-name>, <string-name><surname>Chevalier</surname> <given-names>S</given-names></string-name>, <string-name><surname>Morel</surname> <given-names>F</given-names></string-name>, <string-name><surname>Alderman</surname> <given-names>E</given-names></string-name>, <string-name><surname>Gombert</surname> <given-names>J</given-names></string-name>, <etal>et al.</etal></person-group> <article-title>High circulating leukaemia inhibitory factor (LIF) in patients with giant cell arteritis: independent regulation of LIF and IL-6 under corticosteroid therapy</article-title>. <source>Clin Exp Immunol</source>. <year>1993</year> <month>Apr</month>;<volume>92</volume>(<issue>1</issue>):<fpage>23</fpage>–<lpage>6</lpage>. <pub-id pub-id-type="doi">10.1111/j.1365-2249.1993.tb05942.x</pub-id><pub-id pub-id-type="pmid">8096803</pub-id><issn>0009-9104</issn></mixed-citation></ref>
<ref id="b57"><mixed-citation publication-type="journal" specific-use="restruct"><person-group person-group-type="author"><string-name><surname>Roche</surname> <given-names>NE</given-names></string-name>, <string-name><surname>Fulbright</surname> <given-names>JW</given-names></string-name>, <string-name><surname>Wagner</surname> <given-names>AD</given-names></string-name>, <string-name><surname>Hunder</surname> <given-names>GG</given-names></string-name>, <string-name><surname>Goronzy</surname> <given-names>JJ</given-names></string-name>, <string-name><surname>Weyand</surname> <given-names>CM</given-names></string-name></person-group>. <article-title>Correlation of interleukin-6 production and disease activity in polymyalgia rheumatica and giant cell arteritis</article-title>. <source>Arthritis Rheum</source>. <year>1993</year> <month>Sep</month>;<volume>36</volume>(<issue>9</issue>):<fpage>1286</fpage>–<lpage>94</lpage>. <pub-id pub-id-type="doi">10.1002/art.1780360913</pub-id><pub-id pub-id-type="pmid">8216422</pub-id><issn>0004-3591</issn></mixed-citation></ref>
<ref id="b58"><mixed-citation publication-type="journal" specific-use="restruct"><person-group person-group-type="author"><string-name><surname>van der Geest</surname> <given-names>KS</given-names></string-name>, <string-name><surname>Abdulahad</surname> <given-names>WH</given-names></string-name>, <string-name><surname>Rutgers</surname> <given-names>A</given-names></string-name>, <string-name><surname>Horst</surname> <given-names>G</given-names></string-name>, <string-name><surname>Bijzet</surname> <given-names>J</given-names></string-name>, <string-name><surname>Arends</surname> <given-names>S</given-names></string-name>, <etal>et al.</etal></person-group> <article-title>Serum markers associated with disease activity in giant cell arteritis and polymyalgia rheumatica</article-title>. <source>Rheumatology (Oxford)</source>. <year>2015</year> <month>Aug</month>;<volume>54</volume>(<issue>8</issue>):<fpage>1397</fpage>–<lpage>402</lpage>. <pub-id pub-id-type="doi">10.1093/rheumatology/keu526</pub-id><pub-id pub-id-type="pmid">25724206</pub-id><issn>1462-0324</issn></mixed-citation></ref>
<ref id="b59"><mixed-citation publication-type="journal" specific-use="restruct"><person-group person-group-type="author"><string-name><surname>Terrier</surname> <given-names>B</given-names></string-name>, <string-name><surname>Geri</surname> <given-names>G</given-names></string-name>, <string-name><surname>Chaara</surname> <given-names>W</given-names></string-name>, <string-name><surname>Allenbach</surname> <given-names>Y</given-names></string-name>, <string-name><surname>Rosenzwajg</surname> <given-names>M</given-names></string-name>, <string-name><surname>Costedoat-Chalumeau</surname> <given-names>N</given-names></string-name>, <etal>et al.</etal></person-group> <article-title>Interleukin-21 modulates Th1 and Th17 responses in giant cell arteritis</article-title>. <source>Arthritis Rheum</source>. <year>2012</year> <month>Jun</month>;<volume>64</volume>(<issue>6</issue>):<fpage>2001</fpage>–<lpage>11</lpage>. <pub-id pub-id-type="doi">10.1002/art.34327</pub-id><pub-id pub-id-type="pmid">22147555</pub-id><issn>0004-3591</issn></mixed-citation></ref>
<ref id="b60"><mixed-citation publication-type="journal" specific-use="restruct"><person-group person-group-type="author"><string-name><surname>Ciccia</surname> <given-names>F</given-names></string-name>, <string-name><surname>Alessandro</surname> <given-names>R</given-names></string-name>, <string-name><surname>Rizzo</surname> <given-names>A</given-names></string-name>, <string-name><surname>Principe</surname> <given-names>S</given-names></string-name>, <string-name><surname>Raiata</surname> <given-names>F</given-names></string-name>, <string-name><surname>Cavazza</surname> <given-names>A</given-names></string-name>, <etal>et al.</etal></person-group> <article-title>Expression of interleukin-32 in the inflamed arteries of patients with giant cell arteritis</article-title>. <source>Arthritis Rheum</source>. <year>2011</year> <month>Jul</month>;<volume>63</volume>(<issue>7</issue>):<fpage>2097</fpage>–<lpage>104</lpage>. <pub-id pub-id-type="doi">10.1002/art.30374</pub-id><pub-id pub-id-type="pmid">21452292</pub-id><issn>0004-3591</issn></mixed-citation></ref>
<ref id="b61"><mixed-citation publication-type="journal" specific-use="restruct"><person-group person-group-type="author"><string-name><surname>Weyand</surname> <given-names>CM</given-names></string-name>, <string-name><surname>Hicok</surname> <given-names>KC</given-names></string-name>, <string-name><surname>Hunder</surname> <given-names>GG</given-names></string-name>, <string-name><surname>Goronzy</surname> <given-names>JJ</given-names></string-name></person-group>. <article-title>Tissue cytokine patterns in patients with polymyalgia rheumatica and giant cell arteritis</article-title>. <source>Ann Intern Med</source>. <year>1994</year> <month>Oct</month>;<volume>121</volume>(<issue>7</issue>):<fpage>484</fpage>–<lpage>91</lpage>. <pub-id pub-id-type="doi">10.7326/0003-4819-121-7-199410010-00003</pub-id><pub-id pub-id-type="pmid">8067646</pub-id><issn>0003-4819</issn></mixed-citation></ref>
<ref id="b62"><mixed-citation publication-type="journal" specific-use="restruct"><person-group person-group-type="author"><string-name><surname>Dasgupta</surname> <given-names>B</given-names></string-name>, <string-name><surname>Panayi</surname> <given-names>GS</given-names></string-name></person-group>. <article-title>Interleukin-6 in serum of patients with polymyalgia rheumatica and giant cell arteritis</article-title>. <source>Br J Rheumatol</source>. <year>1990</year> <month>Dec</month>;<volume>29</volume>(<issue>6</issue>):<fpage>456</fpage>–<lpage>8</lpage>. <pub-id pub-id-type="doi">10.1093/rheumatology/29.6.456</pub-id><pub-id pub-id-type="pmid">2124160</pub-id><issn>0263-7103</issn></mixed-citation></ref>
<ref id="b63"><mixed-citation publication-type="journal" specific-use="restruct"><person-group person-group-type="author"><string-name><surname>Beyer</surname> <given-names>C</given-names></string-name>, <string-name><surname>Axmann</surname> <given-names>R</given-names></string-name>, <string-name><surname>Sahinbegovic</surname> <given-names>E</given-names></string-name>, <string-name><surname>Distler</surname> <given-names>JH</given-names></string-name>, <string-name><surname>Manger</surname> <given-names>B</given-names></string-name>, <string-name><surname>Schett</surname> <given-names>G</given-names></string-name>, <etal>et al.</etal></person-group> <article-title>Anti-interleukin 6 receptor therapy as rescue treatment for giant cell arteritis</article-title>. <source>Ann Rheum Dis</source>. <year>2011</year> <month>Oct</month>;<volume>70</volume>(<issue>10</issue>):<fpage>1874</fpage>–<lpage>5</lpage>. <pub-id pub-id-type="doi">10.1136/ard.2010.149351</pub-id><pub-id pub-id-type="pmid">21515917</pub-id><issn>0003-4967</issn></mixed-citation></ref>
<ref id="b64"><mixed-citation publication-type="journal" specific-use="restruct"><person-group person-group-type="author"><string-name><surname>Seitz</surname> <given-names>M</given-names></string-name>, <string-name><surname>Reichenbach</surname> <given-names>S</given-names></string-name>, <string-name><surname>Bonel</surname> <given-names>HM</given-names></string-name>, <string-name><surname>Adler</surname> <given-names>S</given-names></string-name>, <string-name><surname>Wermelinger</surname> <given-names>F</given-names></string-name>, <string-name><surname>Villiger</surname> <given-names>PM</given-names></string-name></person-group>. <article-title>Rapid induction of remission in large vessel vasculitis by IL-6 blockade. A case series</article-title>. <source>Swiss Med Wkly</source>. <year>2011</year> <month>Jan</month>;<volume>141</volume>:<fpage>w13156</fpage>.<pub-id pub-id-type="pmid">21243547</pub-id><issn>1424-3997</issn><annotation><p content-type="warning">Edifix has not found an issue number in the journal reference. Please check the volume/issue information. (Ref. "Seitz, Reichenbach, Bonel, Adler, Wermelinger, Villiger, 2011")</p></annotation></mixed-citation></ref>
<ref id="b65"><mixed-citation publication-type="journal" specific-use="restruct"><person-group person-group-type="author"><string-name><surname>Ferfar</surname> <given-names>Y</given-names></string-name>, <string-name><surname>Mirault</surname> <given-names>T</given-names></string-name>, <string-name><surname>Desbois</surname> <given-names>AC</given-names></string-name>, <string-name><surname>Comarmond</surname> <given-names>C</given-names></string-name>, <string-name><surname>Messas</surname> <given-names>E</given-names></string-name>, <string-name><surname>Savey</surname> <given-names>L</given-names></string-name>, <etal>et al.</etal></person-group> <article-title>Biotherapies in large vessel vasculitis</article-title>. <source>Autoimmun Rev</source>. <year>2016</year> <month>Jun</month>;<volume>15</volume>(<issue>6</issue>):<fpage>544</fpage>–<lpage>51</lpage>. <pub-id pub-id-type="doi">10.1016/j.autrev.2016.02.012</pub-id><pub-id pub-id-type="pmid">26883459</pub-id><issn>1568-9972</issn></mixed-citation></ref>
<ref id="b66"><mixed-citation publication-type="journal" specific-use="restruct"><person-group person-group-type="author"><string-name><surname>Villiger</surname> <given-names>PM</given-names></string-name>, <string-name><surname>Adler</surname> <given-names>S</given-names></string-name>, <string-name><surname>Kuchen</surname> <given-names>S</given-names></string-name>, <string-name><surname>Wermelinger</surname> <given-names>F</given-names></string-name>, <string-name><surname>Dan</surname> <given-names>D</given-names></string-name>, <string-name><surname>Fiege</surname> <given-names>V</given-names></string-name>, <etal>et al.</etal></person-group> <article-title>Tocilizumab for induction and maintenance of remission in giant cell arteritis: a phase 2, randomised, double-blind, placebo-controlled trial</article-title>. <source>Lancet</source>. <year>2016</year> <month>May</month>;<volume>387</volume>(<issue>10031</issue>):<fpage>1921</fpage>–<lpage>7</lpage>. <pub-id pub-id-type="doi">10.1016/S0140-6736(16)00560-2</pub-id><pub-id pub-id-type="pmid">26952547</pub-id><issn>0140-6736</issn></mixed-citation></ref>
<ref id="b67"><mixed-citation publication-type="unknown" specific-use="unparsed"><person-group person-group-type="author"><string-name><surname>Adler</surname> <given-names>S</given-names></string-name>, <string-name><surname>Reichenbach</surname> <given-names>S</given-names></string-name>, <string-name><surname>Kuchen</surname> <given-names>S</given-names></string-name>, <string-name><surname>Wermelinger</surname> <given-names>F</given-names></string-name>, <string-name><surname>Dan</surname> <given-names>D</given-names></string-name>, <string-name><surname>Seitz</surname> <given-names>M</given-names></string-name>, <etal>et al.</etal></person-group> Termination of Tocilizumab-Treatment in Giant Cell Arteritis: Follow-up of Patients after the RCT (ClinicalTrials.gov registration number: NCT01450137) [abstract]. Arthritis Rheumatol. <year>2016</year>;68 (suppl 10).</mixed-citation></ref>
<ref id="b68"><mixed-citation publication-type="unknown" specific-use="unparsed"><person-group person-group-type="author"><string-name><surname>Stone</surname> <given-names>JH</given-names></string-name>, <string-name><surname>Tuckwell</surname> <given-names>K</given-names></string-name>, <string-name><surname>Dimonaco</surname> <given-names>S</given-names></string-name>, <string-name><surname>Klearman</surname> <given-names>M</given-names></string-name>, <string-name><surname>Aringer</surname> <given-names>M</given-names></string-name>, <string-name><surname>Blockmans</surname> <given-names>D</given-names></string-name>, <etal>et al.</etal></person-group> Efficacy and Safety of Tocilizumab in Patients with Giant Cell Arteritis: Primary and Secondary Outcomes from a Phase 3, Randomized, Double-Blind, Placebo-Controlled Trial [abstract]. Arthritis Rheumatol. <year>2016</year>;68 (suppl 10).</mixed-citation></ref>
<ref id="b69"><mixed-citation publication-type="journal" specific-use="restruct"><person-group person-group-type="author"><string-name><surname>Régent</surname> <given-names>A</given-names></string-name>, <string-name><surname>Redeker</surname> <given-names>S</given-names></string-name>, <string-name><surname>Deroux</surname> <given-names>A</given-names></string-name>, <string-name><surname>Kieffer</surname> <given-names>P</given-names></string-name>, <string-name><surname>Ly</surname> <given-names>KH</given-names></string-name>, <string-name><surname>Dougados</surname> <given-names>M</given-names></string-name>, <etal>et al.</etal>; <collab>French Vasculitis Group, the Groupe Francais pour l’Etude de l’Artérite à Cellules Géantes, and the Club Rhumatismes et Inflammation</collab></person-group>. <article-title>Tocilizumab in Giant Cell Arteritis: A Multicenter Retrospective Study of 34 Patients</article-title>. <source>J Rheumatol</source>. <year>2016</year> <month>Aug</month>;<volume>43</volume>(<issue>8</issue>):<fpage>1547</fpage>–<lpage>52</lpage>. <pub-id pub-id-type="doi">10.3899/jrheum.151252</pub-id><pub-id pub-id-type="pmid">27182063</pub-id><issn>0315-162X</issn></mixed-citation></ref>
<ref id="b70"><mixed-citation publication-type="book-chapter" specific-use="restruct"><person-group person-group-type="author"><string-name><surname>Dejaco</surname> <given-names>C</given-names></string-name></person-group>. <chapter-title>Role of steroid-sparing agents</chapter-title>. In: <person-group person-group-type="editor"><string-name><surname>Dasgupta</surname> <given-names>B</given-names></string-name>, <string-name><surname>Dejaco</surname> <given-names>C</given-names></string-name>, <role>editors</role></person-group>. <source>Polymyalgia Rheumatica and Giant Cell Arteritis</source>. <publisher-loc>Oxford</publisher-loc>: <publisher-name>Oxford University Press</publisher-name>; <year>2016</year>. pp. <fpage>89</fpage>–<lpage>95</lpage>.</mixed-citation></ref>
<ref id="b71"><mixed-citation publication-type="journal" specific-use="restruct"><person-group person-group-type="author"><string-name><surname>Ly</surname> <given-names>KH</given-names></string-name>, <string-name><surname>Stirnemann</surname> <given-names>J</given-names></string-name>, <string-name><surname>Liozon</surname> <given-names>E</given-names></string-name>, <string-name><surname>Michel</surname> <given-names>M</given-names></string-name>, <string-name><surname>Fain</surname> <given-names>O</given-names></string-name>, <string-name><surname>Fauchais</surname> <given-names>AL</given-names></string-name></person-group>. <article-title>Interleukin-1 blockade in refractory giant cell arteritis</article-title>. <source>Joint Bone Spine</source>. <year>2014</year> <month>Jan</month>;<volume>81</volume>(<issue>1</issue>):<fpage>76</fpage>–<lpage>8</lpage>. <pub-id pub-id-type="doi">10.1016/j.jbspin.2013.06.004</pub-id><pub-id pub-id-type="pmid">23890680</pub-id><issn>1297-319X</issn></mixed-citation></ref>
<ref id="b72"><mixed-citation publication-type="journal" specific-use="restruct"><person-group person-group-type="author"><string-name><surname>Dasgupta</surname> <given-names>B</given-names></string-name></person-group>. <article-title>A randomised, double-blinded, placebo controlled study to assess the efficacy and safety of gevokizumab in the treatment of giant cell arteritis. Second International Symposium and Imaging Workshop Giant Cell Arteritis, Polymyalgia Rheumatica and Large Vessel Vasculitis</article-title>. <source>Rheumatology</source>. <year>2014</year>;<volume>53</volume> <supplement>suppl.2</supplement>:<fpage>i7</fpage>. <pub-id pub-id-type="doi">10.1093/rheumatology/keu197</pub-id><issn>0080-2727</issn><annotation><p content-type="warning">Edifix has not updated this reference because the article title in Crossref significantly differs from the author's original. The Crossref reference is <underline>Dasgupta B. 12. A randomized, double-blind, placebo-controlled study to assess the efficacy and safety of gevokizumab in the treatment of giant cell arteritis. Rheumatology. 2014 Jul;53 suppl 2:i7</underline>. (Ref. "Dasgupta, 2014")</p></annotation></mixed-citation></ref>
<ref id="b73"><mixed-citation publication-type="journal" specific-use="restruct"><person-group person-group-type="author"><string-name><surname>Espígol-Frigolé</surname> <given-names>G</given-names></string-name>, <string-name><surname>Corbera-Bellalta</surname> <given-names>M</given-names></string-name>, <string-name><surname>Planas-Rigol</surname> <given-names>E</given-names></string-name>, <string-name><surname>Lozano</surname> <given-names>E</given-names></string-name>, <string-name><surname>Segarra</surname> <given-names>M</given-names></string-name>, <string-name><surname>García-Martínez</surname> <given-names>A</given-names></string-name>, <etal>et al.</etal></person-group> <article-title>Increased IL-17A expression in temporal artery lesions is a predictor of sustained response to glucocorticoid treatment in patients with giant-cell arteritis</article-title>. <source>Ann Rheum Dis</source>. <year>2013</year> <month>Sep</month>;<volume>72</volume>(<issue>9</issue>):<fpage>1481</fpage>–<lpage>7</lpage>. <pub-id pub-id-type="doi">10.1136/annrheumdis-2012-201836</pub-id><pub-id pub-id-type="pmid">22993227</pub-id><issn>0003-4967</issn></mixed-citation></ref>
<ref id="b74"><mixed-citation publication-type="journal" specific-use="restruct"><person-group person-group-type="author"><string-name><surname>Ciccia</surname> <given-names>F</given-names></string-name>, <string-name><surname>Rizzo</surname> <given-names>A</given-names></string-name>, <string-name><surname>Guggino</surname> <given-names>G</given-names></string-name>, <string-name><surname>Cavazza</surname> <given-names>A</given-names></string-name>, <string-name><surname>Alessandro</surname> <given-names>R</given-names></string-name>, <string-name><surname>Maugeri</surname> <given-names>R</given-names></string-name>, <etal>et al.</etal></person-group> <article-title>Difference in the expression of IL-9 and IL-17 correlates with different histological pattern of vascular wall injury in giant cell arteritis</article-title>. <source>Rheumatology (Oxford)</source>. <year>2015</year> <month>Sep</month>;<volume>54</volume>(<issue>9</issue>):<fpage>1596</fpage>–<lpage>604</lpage>. <pub-id pub-id-type="doi">10.1093/rheumatology/kev102</pub-id><pub-id pub-id-type="pmid">25862016</pub-id><issn>1462-0324</issn></mixed-citation></ref>
<ref id="b75"><mixed-citation publication-type="journal" specific-use="restruct"><person-group person-group-type="author"><string-name><surname>Chen</surname> <given-names>Q</given-names></string-name>, <string-name><surname>Yang</surname> <given-names>W</given-names></string-name>, <string-name><surname>Gupta</surname> <given-names>S</given-names></string-name>, <string-name><surname>Biswas</surname> <given-names>P</given-names></string-name>, <string-name><surname>Smith</surname> <given-names>P</given-names></string-name>, <string-name><surname>Bhagat</surname> <given-names>G</given-names></string-name>, <etal>et al.</etal></person-group> <article-title>IRF-4-binding protein inhibits interleukin-17 and interleukin-21 production by controlling the activity of IRF-4 transcription factor</article-title>. <source>Immunity</source>. <year>2008</year> <month>Dec</month>;<volume>29</volume>(<issue>6</issue>):<fpage>899</fpage>–<lpage>911</lpage>. <pub-id pub-id-type="doi">10.1016/j.immuni.2008.10.011</pub-id><pub-id pub-id-type="pmid">19062315</pub-id><issn>1074-7613</issn></mixed-citation></ref>
<ref id="b76"><mixed-citation publication-type="journal" specific-use="restruct"><person-group person-group-type="author"><string-name><surname>Márquez</surname> <given-names>A</given-names></string-name>, <string-name><surname>Hernández-Rodríguez</surname> <given-names>J</given-names></string-name>, <string-name><surname>Cid</surname> <given-names>MC</given-names></string-name>, <string-name><surname>Solans</surname> <given-names>R</given-names></string-name>, <string-name><surname>Castañeda</surname> <given-names>S</given-names></string-name>, <string-name><surname>Fernández-Contreras</surname> <given-names>ME</given-names></string-name>, <etal>et al.</etal>; <collab>Spanish GCA Consortium</collab></person-group>. <article-title>Influence of the IL17A locus in giant cell arteritis susceptibility</article-title>. <source>Ann Rheum Dis</source>. <year>2014</year> <month>Sep</month>;<volume>73</volume>(<issue>9</issue>):<fpage>1742</fpage>–<lpage>5</lpage>. <pub-id pub-id-type="doi">10.1136/annrheumdis-2014-205261</pub-id><pub-id pub-id-type="pmid">24919468</pub-id><issn>0003-4967</issn></mixed-citation></ref>
<ref id="b77"><mixed-citation publication-type="journal" specific-use="restruct"><person-group person-group-type="author"><string-name><surname>Miossec</surname> <given-names>P</given-names></string-name>, <string-name><surname>Kolls</surname> <given-names>JK</given-names></string-name></person-group>. <article-title>Targeting IL-17 and TH17 cells in chronic inflammation</article-title>. <source>Nat Rev Drug Discov</source>. <year>2012</year> <month>Oct</month>;<volume>11</volume>(<issue>10</issue>):<fpage>763</fpage>–<lpage>76</lpage>. <pub-id pub-id-type="doi">10.1038/nrd3794</pub-id><pub-id pub-id-type="pmid">23023676</pub-id><issn>1474-1776</issn></mixed-citation></ref>
<ref id="b78"><mixed-citation publication-type="journal" specific-use="restruct"><person-group person-group-type="author"><string-name><surname>Blain</surname> <given-names>H</given-names></string-name>, <string-name><surname>Abdelmouttaleb</surname> <given-names>I</given-names></string-name>, <string-name><surname>Belmin</surname> <given-names>J</given-names></string-name>, <string-name><surname>Blain</surname> <given-names>A</given-names></string-name>, <string-name><surname>Floquet</surname> <given-names>J</given-names></string-name>, <string-name><surname>Guéant</surname> <given-names>JL</given-names></string-name>, <etal>et al.</etal></person-group> <article-title>Arterial wall production of cytokines in giant cell arteritis: results of a pilot study using human temporal artery cultures</article-title>. <source>J Gerontol A Biol Sci Med Sci</source>. <year>2002</year> <month>Apr</month>;<volume>57</volume>(<issue>4</issue>):<fpage>M241</fpage>–<lpage>5</lpage>. <pub-id pub-id-type="doi">10.1093/gerona/57.4.M241</pub-id><pub-id pub-id-type="pmid">11909890</pub-id><issn>1079-5006</issn></mixed-citation></ref>
<ref id="b79"><mixed-citation publication-type="journal" specific-use="restruct"><person-group person-group-type="author"><string-name><surname>Hernández-Rodríguez</surname> <given-names>J</given-names></string-name>, <string-name><surname>Segarra</surname> <given-names>M</given-names></string-name>, <string-name><surname>Vilardell</surname> <given-names>C</given-names></string-name>, <string-name><surname>Sánchez</surname> <given-names>M</given-names></string-name>, <string-name><surname>García-Martínez</surname> <given-names>A</given-names></string-name>, <string-name><surname>Esteban</surname> <given-names>MJ</given-names></string-name>, <etal>et al.</etal></person-group> <article-title>Tissue production of pro-inflammatory cytokines (IL-1beta, TNFalpha and IL-6) correlates with the intensity of the systemic inflammatory response and with corticosteroid requirements in giant-cell arteritis</article-title>. <source>Rheumatology (Oxford)</source>. <year>2004</year> <month>Mar</month>;<volume>43</volume>(<issue>3</issue>):<fpage>294</fpage>–<lpage>301</lpage>. <pub-id pub-id-type="doi">10.1093/rheumatology/keh058</pub-id><pub-id pub-id-type="pmid">14679293</pub-id><issn>1462-0324</issn></mixed-citation></ref>
<ref id="b80"><mixed-citation publication-type="journal" specific-use="restruct"><person-group person-group-type="author"><string-name><surname>Hoffman</surname> <given-names>GS</given-names></string-name>, <string-name><surname>Cid</surname> <given-names>MC</given-names></string-name>, <string-name><surname>Rendt-Zagar</surname> <given-names>KE</given-names></string-name>, <string-name><surname>Merkel</surname> <given-names>PA</given-names></string-name>, <string-name><surname>Weyand</surname> <given-names>CM</given-names></string-name>, <string-name><surname>Stone</surname> <given-names>JH</given-names></string-name>, <etal>et al.</etal>; <collab>Infliximab-GCA Study Group</collab></person-group>. <article-title>Infliximab for maintenance of glucocorticosteroid-induced remission of giant cell arteritis: a randomized trial</article-title>. <source>Ann Intern Med</source>. <year>2007</year> <month>May</month>;<volume>146</volume>(<issue>9</issue>):<fpage>621</fpage>–<lpage>30</lpage>. <pub-id pub-id-type="doi">10.7326/0003-4819-146-9-200705010-00004</pub-id><pub-id pub-id-type="pmid">17470830</pub-id><issn>0003-4819</issn></mixed-citation></ref>
<ref id="b81"><mixed-citation publication-type="journal" specific-use="restruct"><person-group person-group-type="author"><string-name><surname>Martínez-Taboada</surname> <given-names>VM</given-names></string-name>, <string-name><surname>Rodríguez-Valverde</surname> <given-names>V</given-names></string-name>, <string-name><surname>Carreño</surname> <given-names>L</given-names></string-name>, <string-name><surname>López-Longo</surname> <given-names>J</given-names></string-name>, <string-name><surname>Figueroa</surname> <given-names>M</given-names></string-name>, <string-name><surname>Belzunegui</surname> <given-names>J</given-names></string-name>, <etal>et al.</etal></person-group> <article-title>A double-blind placebo controlled trial of etanercept in patients with giant cell arteritis and corticosteroid side effects</article-title>. <source>Ann Rheum Dis</source>. <year>2008</year> <month>May</month>;<volume>67</volume>(<issue>5</issue>):<fpage>625</fpage>–<lpage>30</lpage>. <pub-id pub-id-type="doi">10.1136/ard.2007.082115</pub-id><pub-id pub-id-type="pmid">18086726</pub-id><issn>0003-4967</issn></mixed-citation></ref>
<ref id="b82"><mixed-citation publication-type="journal" specific-use="restruct"><person-group person-group-type="author"><string-name><surname>Seror</surname> <given-names>R</given-names></string-name>, <string-name><surname>Baron</surname> <given-names>G</given-names></string-name>, <string-name><surname>Hachulla</surname> <given-names>E</given-names></string-name>, <string-name><surname>Debandt</surname> <given-names>M</given-names></string-name>, <string-name><surname>Larroche</surname> <given-names>C</given-names></string-name>, <string-name><surname>Puéchal</surname> <given-names>X</given-names></string-name>, <etal>et al.</etal></person-group> <article-title>Adalimumab for steroid sparing in patients with giant-cell arteritis: results of a multicentre randomised controlled trial</article-title>. <source>Ann Rheum Dis</source>. <year>2014</year> <month>Dec</month>;<volume>73</volume>(<issue>12</issue>):<fpage>2074</fpage>–<lpage>81</lpage>. <pub-id pub-id-type="doi">10.1136/annrheumdis-2013-203586</pub-id><pub-id pub-id-type="pmid">23897775</pub-id><issn>0003-4967</issn></mixed-citation></ref>
<ref id="b83"><mixed-citation publication-type="conference" specific-use="unparsed"><person-group person-group-type="author"><string-name><surname>Langford</surname> <given-names>CA</given-names></string-name>, <string-name><surname>Cuthbertson</surname> <given-names>D</given-names></string-name>, <string-name><surname>Ytterberg</surname> <given-names>SR</given-names></string-name>, <string-name><surname>Khalidi</surname> <given-names>NA</given-names></string-name>, <string-name><surname>Monach</surname> <given-names>PA</given-names></string-name></person-group>. <article-title>Carette, et al. A Randomized Double-Blind Trial of Abatacept and Glucocorticoids for the Treatment of Giant Cell Arteritis.</article-title> <source>2015 ACR/ARHP Annual Meeting: Arthritis Rheumatol</source>.; <year>2015</year>;67(suppl.10).</mixed-citation></ref>
<ref id="b84"><mixed-citation publication-type="journal" specific-use="restruct"><person-group person-group-type="author"><string-name><surname>Koster</surname> <given-names>MJ</given-names></string-name>, <string-name><surname>Matteson</surname> <given-names>EL</given-names></string-name>, <string-name><surname>Warrington</surname> <given-names>KJ</given-names></string-name></person-group>. <article-title>Recent advances in the clinical management of giant cell arteritis and Takayasu arteritis</article-title>. <source>Curr Opin Rheumatol</source>. <year>2016</year> <month>May</month>;<volume>28</volume>(<issue>3</issue>):<fpage>211</fpage>–<lpage>7</lpage>. <pub-id pub-id-type="doi">10.1097/BOR.0000000000000265</pub-id><pub-id pub-id-type="pmid">26885650</pub-id><issn>1040-8711</issn></mixed-citation></ref>
<ref id="b85"><mixed-citation publication-type="journal" specific-use="restruct"><person-group person-group-type="author"><string-name><surname>Bhatia</surname> <given-names>A</given-names></string-name>, <string-name><surname>Ell</surname> <given-names>PJ</given-names></string-name>, <string-name><surname>Edwards</surname> <given-names>JC</given-names></string-name></person-group>. <article-title>Anti-CD20 monoclonal antibody (rituximab) as an adjunct in the treatment of giant cell arteritis</article-title>. <source>Ann Rheum Dis</source>. <year>2005</year> <month>Jul</month>;<volume>64</volume>(<issue>7</issue>):<fpage>1099</fpage>–<lpage>100</lpage>. <pub-id pub-id-type="doi">10.1136/ard.2005.036533</pub-id><pub-id pub-id-type="pmid">15958774</pub-id><issn>0003-4967</issn></mixed-citation></ref>
<ref id="b86"><mixed-citation publication-type="journal" specific-use="restruct"><person-group person-group-type="author"><string-name><surname>Mayrbaeurl</surname> <given-names>B</given-names></string-name>, <string-name><surname>Hinterreiter</surname> <given-names>M</given-names></string-name>, <string-name><surname>Burgstaller</surname> <given-names>S</given-names></string-name>, <string-name><surname>Windpessl</surname> <given-names>M</given-names></string-name>, <string-name><surname>Thaler</surname> <given-names>J</given-names></string-name></person-group>. <article-title>The first case of a patient with neutropenia and giant-cell arteritis treated with rituximab</article-title>. <source>Clin Rheumatol</source>. <year>2007</year> <month>Sep</month>;<volume>26</volume>(<issue>9</issue>):<fpage>1597</fpage>–<lpage>8</lpage>. <pub-id pub-id-type="doi">10.1007/s10067-007-0684-0</pub-id><pub-id pub-id-type="pmid">17619810</pub-id><issn>0770-3198</issn></mixed-citation></ref>
<ref id="b87"><mixed-citation publication-type="journal" specific-use="restruct"><person-group person-group-type="author"><string-name><surname>Lally</surname> <given-names>L</given-names></string-name>, <string-name><surname>Pernis</surname> <given-names>A</given-names></string-name>, <string-name><surname>Narula</surname> <given-names>N</given-names></string-name>, <string-name><surname>Huang</surname> <given-names>WT</given-names></string-name>, <string-name><surname>Spiera</surname> <given-names>R</given-names></string-name></person-group>. <article-title>Increased rho kinase activity in temporal artery biopsies from patients with giant cell arteritis</article-title>. <source>Rheumatology (Oxford)</source>. <year>2015</year> <month>Mar</month>;<volume>54</volume>(<issue>3</issue>):<fpage>554</fpage>–<lpage>8</lpage>. <pub-id pub-id-type="doi">10.1093/rheumatology/keu364</pub-id><pub-id pub-id-type="pmid">25213129</pub-id><issn>1462-0324</issn></mixed-citation></ref>
<ref id="b88"><mixed-citation publication-type="journal" specific-use="restruct"><person-group person-group-type="author"><string-name><surname>Piggott</surname> <given-names>K</given-names></string-name>, <string-name><surname>Deng</surname> <given-names>J</given-names></string-name>, <string-name><surname>Warrington</surname> <given-names>K</given-names></string-name>, <string-name><surname>Younge</surname> <given-names>B</given-names></string-name>, <string-name><surname>Kubo</surname> <given-names>JT</given-names></string-name>, <string-name><surname>Desai</surname> <given-names>M</given-names></string-name>, <etal>et al.</etal></person-group> <article-title>Blocking the NOTCH pathway inhibits vascular inflammation in large-vessel vasculitis</article-title>. <source>Circulation</source>. <year>2011</year> <month>Jan</month>;<volume>123</volume>(<issue>3</issue>):<fpage>309</fpage>–<lpage>18</lpage>. <pub-id pub-id-type="doi">10.1161/CIRCULATIONAHA.110.936203</pub-id><pub-id pub-id-type="pmid">21220737</pub-id><issn>0009-7322</issn></mixed-citation></ref>
<ref id="b89"><mixed-citation publication-type="journal" specific-use="restruct"><person-group person-group-type="author"><string-name><surname>Weyand</surname> <given-names>CM</given-names></string-name>, <string-name><surname>Goronzy</surname> <given-names>JJ</given-names></string-name></person-group>. <article-title>Immune mechanisms in medium and large-vessel vasculitis</article-title>. <source>Nat Rev Rheumatol</source>. <year>2013</year> <month>Dec</month>;<volume>9</volume>(<issue>12</issue>):<fpage>731</fpage>–<lpage>40</lpage>. <pub-id pub-id-type="doi">10.1038/nrrheum.2013.161</pub-id><pub-id pub-id-type="pmid">24189842</pub-id><issn>1759-4790</issn></mixed-citation></ref>
<ref id="b90"><mixed-citation publication-type="journal" specific-use="restruct"><person-group person-group-type="author"><string-name><surname>Fernández-Fernández</surname> <given-names>FJ</given-names></string-name></person-group>. <article-title>Treg cells in giant cell arteritis: might they be another target for adjuvant treatment? Comment on the article by Samson et al</article-title>. <source>Arthritis Rheum</source>. <year>2013</year> <month>Jan</month>;<volume>65</volume>(<issue>1</issue>):<fpage>289</fpage>. <pub-id pub-id-type="doi">10.1002/art.37700</pub-id><pub-id pub-id-type="pmid">23001860</pub-id><issn>0004-3591</issn></mixed-citation></ref>
<ref id="b91"><mixed-citation publication-type="journal" specific-use="restruct"><person-group person-group-type="author"><string-name><surname>Zold</surname> <given-names>E</given-names></string-name>, <string-name><surname>Szodoray</surname> <given-names>P</given-names></string-name>, <string-name><surname>Nakken</surname> <given-names>B</given-names></string-name>, <string-name><surname>Barath</surname> <given-names>S</given-names></string-name>, <string-name><surname>Kappelmayer</surname> <given-names>J</given-names></string-name>, <string-name><surname>Csathy</surname> <given-names>L</given-names></string-name>, <etal>et al.</etal></person-group> <article-title>Alfacalcidol treatment restores derailed immune-regulation in patients with undifferentiated connective tissue disease</article-title>. <source>Autoimmun Rev</source>. <year>2011</year> <month>Jan</month>;<volume>10</volume>(<issue>3</issue>):<fpage>155</fpage>–<lpage>62</lpage>. <pub-id pub-id-type="doi">10.1016/j.autrev.2010.09.018</pub-id><pub-id pub-id-type="pmid">20868777</pub-id><issn>1568-9972</issn></mixed-citation></ref>
<ref id="b92"><mixed-citation publication-type="journal" specific-use="restruct"><person-group person-group-type="author"><string-name><surname>Jeffery</surname> <given-names>LE</given-names></string-name>, <string-name><surname>Burke</surname> <given-names>F</given-names></string-name>, <string-name><surname>Mura</surname> <given-names>M</given-names></string-name>, <string-name><surname>Zheng</surname> <given-names>Y</given-names></string-name>, <string-name><surname>Qureshi</surname> <given-names>OS</given-names></string-name>, <string-name><surname>Hewison</surname> <given-names>M</given-names></string-name>, <etal>et al.</etal></person-group> <article-title>1,25-Dihydroxyvitamin D3 and IL-2 combine to inhibit T cell production of inflammatory cytokines and promote development of regulatory T cells expressing CTLA-4 and FoxP3</article-title>. <source>J Immunol</source>. <year>2009</year> <month>Nov</month>;<volume>183</volume>(<issue>9</issue>):<fpage>5458</fpage>–<lpage>67</lpage>. <pub-id pub-id-type="doi">10.4049/jimmunol.0803217</pub-id><pub-id pub-id-type="pmid">19843932</pub-id><issn>0022-1767</issn></mixed-citation></ref>
<ref id="b93"><mixed-citation publication-type="journal" specific-use="restruct"><person-group person-group-type="author"><string-name><surname>Samson</surname> <given-names>M</given-names></string-name>, <string-name><surname>Audia</surname> <given-names>S</given-names></string-name>, <string-name><surname>Fraszczak</surname> <given-names>J</given-names></string-name>, <string-name><surname>Trad</surname> <given-names>M</given-names></string-name>, <string-name><surname>Ornetti</surname> <given-names>P</given-names></string-name>, <string-name><surname>Lakomy</surname> <given-names>D</given-names></string-name>, <etal>et al.</etal></person-group> <article-title>Th1 and Th17 lymphocytes expressing CD161 are implicated in giant cell arteritis and polymyalgia rheumatica pathogenesis</article-title>. <source>Arthritis Rheum</source>. <year>2012</year> <month>Nov</month>;<volume>64</volume>(<issue>11</issue>):<fpage>3788</fpage>–<lpage>98</lpage>. <pub-id pub-id-type="doi">10.1002/art.34647</pub-id><pub-id pub-id-type="pmid">22833233</pub-id><issn>0004-3591</issn></mixed-citation></ref>
<ref id="b94"><mixed-citation publication-type="journal" specific-use="restruct"><person-group person-group-type="author"><string-name><surname>Berod</surname> <given-names>L</given-names></string-name>, <string-name><surname>Friedrich</surname> <given-names>C</given-names></string-name>, <string-name><surname>Nandan</surname> <given-names>A</given-names></string-name>, <string-name><surname>Freitag</surname> <given-names>J</given-names></string-name>, <string-name><surname>Hagemann</surname> <given-names>S</given-names></string-name>, <string-name><surname>Harmrolfs</surname> <given-names>K</given-names></string-name>, <etal>et al.</etal></person-group> <article-title>De novo fatty acid synthesis controls the fate between regulatory T and T helper 17 cells</article-title>. <source>Nat Med</source>. <year>2014</year> <month>Nov</month>;<volume>20</volume>(<issue>11</issue>):<fpage>1327</fpage>–<lpage>33</lpage>. <pub-id pub-id-type="doi">10.1038/nm.3704</pub-id><pub-id pub-id-type="pmid">25282359</pub-id><issn>1078-8956</issn><annotation><p content-type="warning">CrossMark reports an erratum (or similar issue). The CrossMark type is "erratum". Additional information can be found at https://doi.org/10.1038/nm0415-414d. (Ref. "Berod, Friedrich, Nandan, Freitag, Hagemann, Harmrolfs, et al., 2014")</p></annotation></mixed-citation></ref>
<ref id="b95"><mixed-citation publication-type="journal" specific-use="restruct"><person-group person-group-type="author"><string-name><surname>Martinez-Taboada</surname> <given-names>VM</given-names></string-name>, <string-name><surname>Blanco</surname> <given-names>R</given-names></string-name>, <string-name><surname>Fito</surname> <given-names>C</given-names></string-name>, <string-name><surname>Pacheco</surname> <given-names>MJ</given-names></string-name>, <string-name><surname>Delgado-Rodriguez</surname> <given-names>M</given-names></string-name>, <string-name><surname>Rodriguez-Valverde</surname> <given-names>V</given-names></string-name></person-group>. <article-title>Circulating CD8+ T cells in polymyalgia rheumatica and giant cell arteritis: a review</article-title>. <source>Semin Arthritis Rheum</source>. <year>2001</year> <month>Feb</month>;<volume>30</volume>(<issue>4</issue>):<fpage>257</fpage>–<lpage>71</lpage>. <pub-id pub-id-type="doi">10.1053/sarh.2001.9734</pub-id><pub-id pub-id-type="pmid">11182026</pub-id><issn>0049-0172</issn></mixed-citation></ref>
<ref id="b96"><mixed-citation publication-type="journal" specific-use="restruct"><person-group person-group-type="author"><string-name><surname>Elling</surname> <given-names>P</given-names></string-name>, <string-name><surname>Olsson</surname> <given-names>AT</given-names></string-name>, <string-name><surname>Elling</surname> <given-names>H</given-names></string-name></person-group>. <article-title>Reduced CD8+ T-cell concentration in peripheral blood of patients with carotid artery stenosis: relation to arteritis temporalis</article-title>. <source>Br J Rheumatol</source>. <year>1996</year> <month>Jul</month>;<volume>35</volume>(<issue>7</issue>):<fpage>649</fpage>–<lpage>51</lpage>. <pub-id pub-id-type="doi">10.1093/rheumatology/35.7.649</pub-id><pub-id pub-id-type="pmid">8670598</pub-id><issn>0263-7103</issn></mixed-citation></ref>
<ref id="b97"><mixed-citation publication-type="journal" specific-use="restruct"><person-group person-group-type="author"><string-name><surname>Samson</surname> <given-names>M</given-names></string-name>, <string-name><surname>Ly</surname> <given-names>KH</given-names></string-name>, <string-name><surname>Tournier</surname> <given-names>B</given-names></string-name>, <string-name><surname>Janikashvili</surname> <given-names>N</given-names></string-name>, <string-name><surname>Trad</surname> <given-names>M</given-names></string-name>, <string-name><surname>Ciudad</surname> <given-names>M</given-names></string-name>, <etal>et al.</etal></person-group> <article-title>Involvement and prognosis value of CD8(+) T cells in giant cell arteritis</article-title>. <source>J Autoimmun</source>. <year>2016</year> <month>Aug</month>;<volume>72</volume>:<fpage>73</fpage>–<lpage>83</lpage>. <pub-id pub-id-type="doi">10.1016/j.jaut.2016.05.008</pub-id><pub-id pub-id-type="pmid">27236507</pub-id><issn>0896-8411</issn><annotation><p content-type="warning">Edifix has not found an issue number in the journal reference. Please check the volume/issue information. (Ref. "Samson, Ly, Tournier, Janikashvili, Trad, Ciudad, et al., 2016")</p></annotation></mixed-citation></ref>
<ref id="b98"><mixed-citation publication-type="journal" specific-use="restruct"><person-group person-group-type="author"><string-name><surname>Nadkarni</surname> <given-names>S</given-names></string-name>, <string-name><surname>Dalli</surname> <given-names>J</given-names></string-name>, <string-name><surname>Hollywood</surname> <given-names>J</given-names></string-name>, <string-name><surname>Mason</surname> <given-names>JC</given-names></string-name>, <string-name><surname>Dasgupta</surname> <given-names>B</given-names></string-name>, <string-name><surname>Perretti</surname> <given-names>M</given-names></string-name></person-group>. <article-title>Investigational analysis reveals a potential role for neutrophils in giant-cell arteritis disease progression</article-title>. <source>Circ Res</source>. <year>2014</year> <month>Jan</month>;<volume>114</volume>(<issue>2</issue>):<fpage>242</fpage>–<lpage>8</lpage>. <pub-id pub-id-type="doi">10.1161/CIRCRESAHA.114.301374</pub-id><pub-id pub-id-type="pmid">24158630</pub-id><issn>0009-7330</issn></mixed-citation></ref>
</ref-list>
</back>
</article>
